Earnings, Acquisitions, and an Oversold Position Pushing Biotechs Up



Image Credit: Marco Verch (Flickr)


Biotech Earnings Reports and M&A Activity Contribute to Sector Strength

Biotech stocks that were on life support during the beginning of 2022 are now revived and not slowing down. Since mid-June, when many sectors turned around, the beaten-up biotechs became impressive outperformers. And, for good reasons. While they may have overshot on the high side during the pandemic, the post-pandemic selling may have also gone too far, currently, they are priced at levels that has generated a lot of interest among investors, both small and large.

The SPDR S&P Biotech ETF (XBI), which tracks the sector, is up 16.35% over the past three months and 45.14%% since the markets closed on June 14. XBI had fallen from the $110 range to the $60 range earlier this year, it is now around $92. Whether or not this represents a continued direction for the biotech sector remains to be seen, but the positive buzz and news stories surrounding biotech seem to be increasing.


Right Mixture

Merck (MRK) has been in the news as they’re in negotiations to acquire Seagen (SGEN). This has been a reminder that big pharma is flush with cash, so much that attractive small and mid-cap biotech companies can easily be purchased without a financial blink from the acquirer. These smaller companies are also finding it easier to develop financial and R&D partnerships with big companies. The financial strength of big pharma has been further highlighted in recent weeks as stock buybacks among large firms and merger activity seem to be growing. Market-moving drug-testing results are also being reported as the FDA is less distracted than it has been in years. Taken together, all of these factors would seem to be the right treatment to continue to heal and strengthen a depressed sector.


Source: Koyfin

The market is also being reminded of the potential profitability of the sector during this earnings
season
. Companies like Regeneron Pharmaceuticals (REGN) climbed almost 6% after reporting earnings this week, and Gilead Sciences (GILD) financial reporting had a similar impact on its stock price. But these didn’t even come close to Moderna (MRNA) which gained 16% after reporting its earnings.

As for the smaller biotech names, both public and private are also deals being made. Gilead announced an agreement on Thursday to pick up a private U.K.-based biotech called MiroBio for $405 million in cash.

The sector has gained much of its strength of the sector in recent months from mid-caps that were weaker than their larger counterparts early in the year. Names like Therapeutics (BEAM), which started the year off poorly but is now up 104% since mid-June. Fate Therapeutics (FATE) is another mid cap that has been flying since mid-June and is currently up 77% during that period.


Take Away

Markets are cyclical, and the biotech sector, which was at the height of its cycle earlier this decade, may have recently passed the bottom of its cycle. Smaller names are now at attractive levels for cash-rich larger pharmaceutical companies to scoop up companies that operate in areas they are looking to strengthen their pipeline or offerings.

A great place to find and explore small biotechs is Channelchek. Simply click on Company
Data
at the upper left of your screen, then healthcare, which leads you to a drop-down menu with biotech as one of the categories. Sign up for research on small and microcap companies from top-ranked analysts in biotech and other industries, delivered to your inbox each morning.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



Is Biotech’s Outperformance Reaching a New Stage of Development?



What Investors Haven’t Yet Noticed About the Value in Some Biotechs




Energy and Global Fundamentals Make a Good Case for Owning Western Uranium



Science Fiction Becoming Medicines Future


Sources

https://www.barrons.com/articles/biotech-stocks-rally-bear-market-51657551507

https://www.barrons.com/articles/bull-market-biotech-stocks-51659620438?mod=hp_LEAD_2_B_2

Stay up to date. Follow us:

 

Avivagen Inc. (VIVXF) – AB Vista Gets on the Board

Friday, August 05, 2022

Avivagen Inc. (VIVXF)
AB Vista Gets on the Board

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A Pathway Into Brazil. Avivagen’s management announced Wednesday that the Company has received a 1.2 tonne order of OxC-beta from AB Vista that will be shipped for use in Brazil. It will be used for ongoing trials with several large poultry and cattle producers. We believe that this is a stepping stone in Avivagen’s aggressive marketing in OxC-beta, as the order represents increased awareness of the product.

Brazil Market. As a reminder, AB Vista is the exclusive distribution partner for Avivagen in the United States, Brazil, and Thailand. Brazil is the third largest for animal feed behind China and the U.S., and produced 80.1mmt in 2021. We anticipate more deals coming from the Brazil market, as AB Vista has existing relationships and distribution partnerships it can use to further sales of the OxC-beta product….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

More Behind AMC’s APE Dividend than Meets the Eye



Image Credit: Keith C (Flickr)


AMC Announces Peculiar Dividend and a New Class of Company Stock

“So, ladies and gentlemen, gentlemen and ladies, TODAY WE POUNCE.” In his letter to shareholders, these are the words of AMC Theatres CEO Adam Aron. Amidst a flurry of reports, filings, and an open letter to shareholders yesterday (August 4), the company announced a unique dividend to be awarded to listed shareholders later this month. The AMC Preferred Equity announcement (ticker: APE) is causing as much or more confusion as the unusual GameStop (GME) dividend did last month.

Below we try to simplify the details of the new APE units.


Details of Dividend

The special dividend of one AMC Preferred Equity unit will be issued for each share of AMC Class A common stock outstanding at the close of business on August 15, 2022. The special dividend is scheduled to be paid at the close of business on August 19. AMC expects to list its AMC Preferred Equity Units on the NYSE under the symbol “APE,” starting August 22. The symbol is a familiar term to the so-called meme stock investors who often refer to themselves as “apes.”

AMC will be issuing one share of APE as a dividend for each of its 516,820,595 shares outstanding, according to Aron. “The issuance only to our shareholders of tradable AMC Preferred Equity units clarifies who is included in our current shareholder base,” he said in a press release. The company has faced questions and theories that there are synthetic AMC shares in the hands of unwitting investors. Aron believes this can answer those questions by vetting through their shareholder of record list.


Source: Twitter (@PeterRHann1)

The theory that there are fraudulent shares in the float used by investors to cover short positions in the past could now be uncovered. Some online commentators argue that if they can add synthetic AMC, then they can add synthetic APE to trade. However, AMC took an extra step. An NFT. Bypassing the blockchain and creating fraudulent NFTs would, in theory, be more difficult, if only because it would take a different skill set. The “I own APE” NFT will be given to shareholders of record August 14.

 

What Shareholders Get

The company stock price has had wide swings over the past two years that took the theater chain from a down-for-the-count pandemic victim to a Robinhood investor phenomenon. AMC tapped the steep rise in its share price to raise $917 million in January 2021. At that time, Aron said the new financing meant any talk of imminent bankruptcy “is completely off the table.”






Source: Twitter (@CEOAdam)

Earlier this year, AMC stunned Wall Street when it made a $27.
9 million investment
in Hycroft Mining Holding Corp. HYMC, a gold and silver mining company that diversifies AMC well outside of the entertainment industry. He spoke of the ownership interest on an investor call this week, saying, “We have every confidence that our Hycroft investment will pan out, excuse the pun, to be quite lucrative for AMC,” he said. “I am so convinced that, when the story is finally written, this will be a good one for AMC.”

Shares of the company, which skyrocketed to a high of $72.62 on June 2, 2021, have fallen 30% this year.


Source: AMC Website (AMC Preferred Equity Units)

The new class of stock is convertible into AMC common shares at one-to-one and conversion is at the discretion of the holder. It is designed to not add any dilution for current (authentic) shareholders. The ability to vote APE units will be the same for both classes of shares. APE shares have preferred rights and claims over the AMC class, making AMC shares subordinate in a liquidation event.


What AMC Gets

“This new AMC Preferred Equity gives AMC a currency that can be used in the future to strengthen our balance sheet, including by paying down debt or raising fresh equity,” said AMC Chief Executive Adam Aron. “As a result, this dramatically lessens any near-term survival risk for AMC, as we continue to work our way through this pandemic.” In the letter to shareholders he explained, “I believe all of this makes us vastly, and I mean, vastly, stronger.” The Aron, referred to AMC’s critics as “naysayers” and “prophets of doom” and took a shot at those shorting the stock by saying the dividend is very bad news for people “not rooting for AMC.”


Source: AMC Theatres Press Release (August 4, 2022)

Take-Away

The AMC dividend is unique. It adds a new class of company stocks that does not mathematically devalue the company. It appears to be designed to give investors confidence that each share traded is authentic. Less importantly, it allows investors that refer to themselves as Apes to own a favorite company trading under the ticker APE. Separately, it gives a nod to blockchains’ ability to provide authenticity through NFTs.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



The GameStop Stock Split Dividend is More Genius than it Appears



AMC is Thinking Outside the Box Office and Diversifying




Michael Burry Calls Out Fed for Not Following Plan It Just Laid Out



A Small Cap Leading Indicator on Whether or Not We’re in a Recession

Sources

https://d18rn0p25nwr6d.cloudfront.net/CIK-0001411579/d143ef2b-7a84-47d2-a8a1-7930f7527930.pdf

https://s25.q4cdn.com/472643608/files/doc_financials/2022/q2/FINAL-APE-Dividend-Press-Release-20220804-0930-v.F-clean.pdf

https://s25.q4cdn.com/472643608/files/doc_downloads/2022/FINAL-APE-Dividend-Shareholder-Letter-20220804-1400-v.F.pdf

https://s25.q4cdn.com/472643608/files/doc_downloads/AMC_Preferred-Equity-Units_WEBSITE-(Weil-8.3.2022).pdf

https://twitter.com/CEOAdam/status/1555324348852047872/photo/1


Stay up to date. Follow us:

 

Release – Motorsport Games and BTCC Announce “BTCC rFactor 2 Hot Lap Challenge” for Final Four Events of the Season



Motorsport Games and BTCC Announce “BTCC rFactor 2 Hot Lap Challenge” for Final Four Events of the Season

Research, News, and Market Data on Motorsport Games

MIAMI, Aug. 05, 2022 (GLOBE NEWSWIRE) — Motorsport Games Inc. (NASDAQ:
MSGM) (“Motorsport Games” or the “Company”)
, a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world, in conjunction with the British
Touring Car Championship (BTCC),
 announces today the BTCC
rFactor 2 Hot Lap Challenge
. The challenge will be available for fans to participate in at the final four race weekends of the 2022 BTCC season. Visitors who also register for the Motorsport Games/BTCC mailing list will be among the first to receive exclusive news and updates on the upcoming BTCC game, slated for full release in 2024.

Ticket holders at each event are welcome to stop by the Motorsport Games x BTCC booth in order to experience official BTCC content within rFactor 2, the realistic racing simulation platform. Fans will compete to post their hot lap time (Time2Beat), with the best posted result winning the signed gear grand prize. The booth will feature four racing simulators pre-loaded with a rFactor 2 tech demo, running official BTCC cars and tracks. Free giveaways will also be available while supplies last. The BTCC rFactor 2 Hot Lap Challenge will be available to play at the following race weekends:

  • Snetterton (Norfolk, UK): August 13-14, 2022
  • Thruxton (Hampshire, UK): August 27-28, 2022
  • Silverstone National (Towcester, UK): September 24-25, 2022
  • Brands Hatch GP (Kent, UK): October 8-9, 2022

“The launch of the BTCC rFactor 2 Hot Lap Challenge is one of the many ways in which Motorsport Games is bringing this iconic motorsport series to life for fans to enjoy,” said Dmitry Kozko, CEO of Motorsport
Games
. “This activation, a part of four events this season, provides a first look at the BTCC brought to life within the virtual world. By bringing the BTCC into the Motorsport Games fold, we are continuing to enhance our product differentiation within a robust racing games marketplace for fans across the globe.”

The BTCC rFactor 2 Hot Lap Challenge serves the goal for both Motorsport Games and the BTCC of refining and strengthening the future BTCC game title, scheduled to arrive in 2024. Fans who take part in the Time2Beat activations will be able to provide real time feedback that will be used in the game’s development. The hot lap challenges are a part of the larger promotional plan update previously announced by Motorsport Games, including additional activations, content releases and ‘first-play content’ tech demos through rFactor 2 containing BTCC content.

“The BTCC rFactor 2 Hot Lap Challenge being brought to our events is yet another way we are ensuring a memorable fan experience at our races,” said Alan Gow, BTCC Chief Executive. “We know that our fans are eager to get their hands on the official BTCC game and we ensure that progress and expanded development plans are continuing to be made in the here and now. We look forward to hearing the fans’ feedback directly and having another entertaining and engaging experience available during race weekends.”

Motorsport Games plans to continue adding additional BTCC branded content into rFactor 2. Motorsport Games and rFactor 2 have already added the Infiniti Q50 and Toyota Corolla BTCC cars into the simulation for fans to drive as part of a first content rollout. Daily BTCC competitions through the rFactor 2 competition system will be open to all users, allowing for statistics-driven benefits to each driver’s rating. All content released via rFactor 2 will be utilized as a technical test bed, allowing consumers and official drivers to provide feedback for the development team and help build the best experience upon full release.

To keep up with the latest Motorsport Game news, visit www.motorsportgames.com and follow on Twitter, Instagram, Facebook and LinkedIn.

About Motorsport Games:
Motorsport Games, a Motorsport Network company, is a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world. Combining innovative and engaging video games with exciting esports competitions and content for racing fans and gamers, Motorsport Games strives to make the joy of racing accessible to everyone. The Company is the officially licensed video game developer and publisher for iconic motorsport racing series across PC, PlayStation, Xbox, Nintendo Switch and mobile, including NASCAR, INDYCAR, 24 Hours of Le Mans and the British Touring Car Championship (“BTCC”), as well as the industry leading rFactor 2 and KartKraft simulations. RFactor 2 also serves as the official sim racing platform of Formula E. Motorsport Games is an award-winning esports partner of choice for 24 Hours of Le Mans, Formula E, BTCC, the FIA World Rallycross Championship and the eNASCAR Heat Pro League, among others. Motorsport Games is building a virtual racing ecosystem where each product drives excitement, every esports event is an adventure and every story inspires.

About the British Touring Car Championship:
The British Touring Car Championship (BTCC) was formed in 1958 and is Britain’s most popular motor racing spectacle with its race season comprising ten events at top circuits across the UK. It is contested by professional racing drivers in competition versions of every day road cars, giving it tremendous public appeal. Over 380,000 watch the BTCC trackside each year and it receives widespread UK terrestrial TV exposure on the ITV network, with all ten events broadcast live across ITV, ITV4 and itv.com.

The 2022 campaign marks the start of the BTCC’s Hybrid Era, as the championship becomes the first touring car series in the world to integrate hybrid power into all of its race cars.

Forward-Looking Statements:
Certain statements in this press release which are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are provided pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, statements concerning the expected future impact of new or planned products, features and/or offerings and the timing of launching such products, features and/and offerings, including, without limitation Motorsport Games’ plans to continue to enhance its product differentiation within a robust racing games marketplace for fans across the globe, that the BTCC rFactor 2 Hot Lap Challenge serves the goal for both Motorsport Games and the BTCC of refining and strengthening the future BTCC game title, scheduled to arrive in 2024, Motorsport Games’ plans to continue adding additional BTCC branded content into rFactor 2 and that the daily BTCC competitions will help build the best experience upon the games’ full release. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Motorsport Games and are difficult to predict. Examples of such risks and uncertainties include, without limitation, difficulties, delays in or unanticipated events that may impact the timing and scope of new product launches, such as due to: (i) difficulties or delays in using its product development personnel in Russia due to the Russia invasion of Ukraine and the related sanctions and/or more restrictive sanctions rendering transacting in the region more difficult or costly and/or difficulties and/or delays arising out of any resurgence of the ongoing and prolonged COVID-19 pandemic; (ii) less than expected benefits from implementing the Company’s management strategies; (iii) adverse economic, market and geopolitical conditions that negatively impact industry trends, such as significant changes in the labor markets, an extended or higher than expected inflationary environment (such as the impact on consumer discretionary spending as a result of significant increases in energy and gas prices which have been increasing since early in 2020), a higher interest rate environment, tax increases impacting consumer discretionary spending and/or quantitative easing that results in higher interest rates that negatively impact consumers’ discretionary spending; and/or (iv) difficulties and/or delays in resolving our liquidity position and financial condition by obtaining additional capital to meet our liquidity needs, including without limitation, difficulties in securing funding that is on commercially acceptable terms to us or at all, such as our inability to complete in whole or in part any potential debt and/or equity financing transactions, as well as any inability to achieve cost reductions and/or less than expected availability of funds under Motorsport Games’ $12 million line of credit from Motorsport Network. Factors other than those referred to above could also cause Motorsport Games’ results to differ materially from expected results. Additional examples of such risks and uncertainties include, but are not limited to: (i) delays and higher than anticipated expenses related to the ongoing and prolonged COVID-19 pandemic and any resurgence of COVID-19; (ii) Motorsport Games’ ability (or inability) to maintain existing, and to secure additional, licenses and other agreements with various racing series; (iii) Motorsport Games’ ability to successfully manage and integrate any joint ventures, acquisitions of businesses, solutions or technologies; (iv) unanticipated operating costs, transaction costs and actual or contingent liabilities; (v) the ability to attract and retain qualified employees and key personnel; (vi) adverse effects of increased competition; (vii) Motorsport Games’ ability to protect its intellectual property; and/or (viii) local, industry and general business and economic conditions. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in Motorsport Games’ filings with the Securities and Exchange Commission (the “SEC”), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, its Quarterly Reports on Form 10-Q filed with the SEC during 2022, as well as in its subsequent filings with the SEC. Motorsport Games anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Motorsport Games assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Motorsport Games’ plans and expectations as of any subsequent date. Additionally, the business and financial materials and any other statement or disclosure on, or made available through, Motorsport Games’ website or other websites referenced or linked to this press release shall not be incorporated by reference into this press release.

Website and Social Media Disclosure:

Investors and others should note that we announce material financial information to our investors using our investor relations website (ir.motorsportgames.com), SEC filings, press releases, public conference calls and webcasts. We use these channels, as well as social media and blogs, to communicate with our investors and the public about our company and our products. It is possible that the information we post on our websites, social media and blogs could be deemed to be material information. Therefore, we encourage investors, the media and others interested in our company to review the information we post on the websites, social media channels and blogs, including the following (which list we will update from time to time on our investor relations website):

Websites

Social Media

motorsportgames.com

Twitter: @msportgames & @traxiongg

traxion.gg

Instagram: msportgames & traxiongg

motorsport.com

Facebook: Motorsport Games & traxiongg

 

LinkedIn: Motorsport Games

 

Twitch: traxiongg

 

Reddit: traxiongg

The contents of these websites and social media channels are not part of, nor will they be incorporated by reference into, this press release.

Press:
ASTRSK PR
motorsportgames@astrskpr.com

BTCC Media Office
Simon Melluish or Emma Illman
Tel. +44 (0) 1372 414120
Email. 
simon.melluish@mpacreative.com or emma.illman@mpacreative.com

 


Release – Reminder: Direct Digital Holdings to Report Second Quarter 2022 Financial Results



Reminder: Direct Digital Holdings to Report Second Quarter 2022 Financial Results

Research, News, and Market Data on Direct Digital Holdings

August 04, 2022 9:00am EDT
Download as PDF

HOUSTON, Aug. 4, 2022  /PRNewswire/ — Direct Digital Holdings (Nasdaq: DRCT) (“Direct Digital”), a leading advertising and marketing technology platform and owner of operating companies Colossus SSP, Huddled Masses and Orange 142, will report financial results for the second quarter ended June 30, 2022, on Thursday, August 11, 2022 after the U.S. stock market closes. Management will host a conference call and webcast on the same day at 5:00 P.M. ET to discuss the results.

 

The live webcast and replay can be accessed at https://ir.directdigitalholdings.com/.

About
Direct Digital Holdings
Direct Digital Holdings (Nasdaq: DRCT), owner of operating companies Colossus SSP, Huddled Masses and Orange 142, brings state-of-the-art sell- and buy-side advertising platforms together under one umbrella company. Direct Digital Holdings’ sell-side platform, Colossus SSP, offers advertisers of all sizes extensive reach within general market and multicultural media properties. The company’s subsidiaries Huddled Masses and Orange142 deliver significant ROI for middle market advertisers by providing data-optimized programmatic solutions at scale for businesses in sectors that range from energy to healthcare to travel to financial services. Direct Digital Holdings’ sell- and buy-side solutions manage approximately 70,000 clients monthly, generating over 90 billion impressions per month across display, CTV, in-app and other media channels. The company has been named a top minority-owned business by The Houston Business Journal.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/reminder-direct-digital-holdings-to-report-second-quarter-2022-financial-results-301599633.html

SOURCE Direct Digital Holdings

Released August 4, 2022

 

Release – Ocugen Provides Business Update & Second Quarter 2022 Financial Results



Ocugen Provides Business Update & Second Quarter 2022 Financial Results

Research, News, and Market Data on Ocugen

CONFERENCE CALL AND WEBCAST TODAY AT 8:30 A.M. ET

 

  • Dosing
    patients in U.S. Phase 2/3 COVAXIN™ (BBV152) clinical trial
  • Completed
    dosing of patients in Cohort 1 of OCU400 gene therapy product candidate
  • Expanding
    product pipeline with the regenerative medicine cell therapy program
    NeoCart
    ®

MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today reported financial results for the quarter ended June 30, 2022, and provided a general business update.

“The second quarter was marked by several important milestones,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. “On the vaccine front, we continued to work diligently with our co-development partner, Bharat Biotech, to ensure we execute our planned clinical and commercial objectives for COVAXIN™ – a whole-virion inactivated COVID-19 vaccine candidate.”

“We are also excited and encouraged by the positive momentum of our investigational modifier gene therapy platform, with the potential to address many different gene mutations in the retina and look forward to bringing hope to patients for whom no treatment options exist,” Dr. Musunuri added.

During the second quarter, Ocugen expanded its dynamic clinical product pipeline with the introduction of NeoCart®, an innovative Phase 3-ready cell therapy platform. The U.S. Food and Drug Administration (FDA) recently granted NeoCart® a Regenerative Medicine Advanced Therapy (RMAT) designation for the repair of full-thickness lesions of the knee cartilage in adults, and this candidate, if approved, offers the potential for a new therapeutic option in this area.

“With our diversified portfolio, Ocugen is well-positioned to advance our product development efforts and we look forward to sharing key data as these programs progress,” Dr. Musunuri concluded.

Clinical and Business
Updates

Vaccines

  • COVAXIN™ Development in the
    United States
     – The Phase 2/3 immuno-bridging and broadening clinical trial, OCU-002, for COVAXIN™ is progressing well.
    • The Company is actively engaged in planning for the initiation of an adult safety clinical trial this year.
  • COVAXIN™ Data Published in
    Scientific Journals
     – In June 2022, positive pediatric Phase 2/3 study results in children aged 2-18 years were published in The Lancet Infectious Diseases. A study published in Nature
    Scientific Reports
     in July shows that COVAXIN™ (BBV152) generated a persistent cell mediated memory immune response for up to 12 months. Additionally, a booster dose is safe and ensures persistent immunity to minimize breakthrough infections of COVID-19.

Gene Therapies

  • OCU400 Clinical Trial – Dosing of subjects with retinitis pigmentosa in Cohort 1 was completed. Previously, the Company reported “first patient, first dose” in late March 2022.
    • The Independent Data and Safety Monitoring Board (DSMB) for the clinical trial recently completed a review of safety data based on dosing from Cohort 1 and recommends proceeding to dosing in Cohort 2. The Company expects to begin dosing in Cohort 2 this month.
  • OCU410 Development Program – Ocugen is conducting IND-enabling studies as per discussions with the FDA. A clinical trial is scheduled to begin next year, and the Company is currently manufacturing materials to support the clinical trial.
  • Improved Patent Estate – In June 2022, the Company announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,351,225, which is directed to methods for preventing or treating an ocular disease or disorder associated with retinal degenerative disease. The patent covers the use of a nuclear hormone receptor gene, such as nuclear receptor subfamily 2 group E member 3 (NR2E3), RAR-related orphan receptor A (RORA), Nuclear Protein 1, Transcriptional Regulator (NUPR1), and Nuclear Receptor Subfamily 2 Group C Member 1 (NR2C1), in treating retinal degenerative diseases as well as reducing the risk of developing such diseases.

Cell Therapies

  • Expansion of Product Candidate
    Pipeline with NeoCart
    ® – Ocugen added NeoCart®, a Phase 3-ready cell therapy platform technology to its diverse product candidate pipeline. The Company originally acquired NeoCart® as part of the Company’s reverse merger with Histogenics Corporation in 2019. Ocugen is currently working with the FDA to finalize the Phase 3 protocol necessary to advance the clinical development program of NeoCart®. Also, the Company entered into a collaborative research agreement with Brigham and Women’s Hospital, Harvard Medical School, to support NeoCart® development and explore expansion of the pipeline.

Other Business

  • At-the-Market Stock Issuance – In June 2022, the Company announced it had entered into an At Market Issuance Sales Agreement relating to the sale of shares of Ocugen’s common stock having an aggregate gross sales price of up to $160.0 million. Proceeds will be used for general corporate purposes.
  • Community Recognition – In June 2022, the Philadelphia Business
    Journal
     named Ocugen among the region’s “2022 Best Places to Work.”

Second Quarter 2022
Financial Results

  • The Company’s cash, cash equivalents, and restricted cash totaled $115.0 million as of June 30, 2022, compared to $95.1 million as of December 31, 2021. The Company believes that its current cash and cash equivalents balance will enable it to fund its operations into the second quarter of 2023. The Company had 216.1 million shares of common stock outstanding as of June 30, 2022.
  • Research and development expenses for the three months ended June 30, 2022, were $9.0 million compared to $18.9 million for the three months ended June 30, 2021. Research and development expenses for the three months ended June 30, 2021, included a $15.0 million upfront payment to Bharat Biotech for the right and license to COVAXIN™ development, manufacturing, and commercialization in Canada.  
  • General and administrative expenses for the three months ended June 30, 2022, were $10.6 million compared to $6.8 million for the three months ended June 30, 2021.
  • Ocugen reported a $0.09 net loss per share for the three months ended June 30, 2022, compared to a $0.13 net loss per share for the three months ended June 30, 2021.

Conference Call and
Webcast Details

Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen’s executive management team will host the call, which will be open to all listeners. There will also be a question-and-answer session following the prepared remarks.

Attendees are invited to participate on the call using the following details:

Dial-in Numbers: (800) 715-9871 for U.S. callers and (646) 307-1963 for international callers
Conference ID: 7036957
Webcast: Available on the events section of the Ocugen investor site

A replay of the call and archived webcast will be available for approximately 45 days following the event on the Ocugen investor site.

About Ocugen, Inc.
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patient’s lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. 

Discover more at www.ocugen.com and follow us on Twitter and LinkedIn.

Cautionary Note on
Forward-Looking Statements

This press release contains forward-looking statements within the meaning of
The Private Securities Litigation Reform Act of 1995, which are subject to
risks and uncertainties. We may, in some cases, use terms such as “predicts,”
“believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,”
“expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or
other words that convey uncertainty of future events or outcomes to identify
these forward-looking statements. Such forward-looking statements include, but
are not limited to, statements about the potential for NeoCart
® (autologous chondrocyte-derived neocartilage), if
approved, to provide an innovative new option for the repair of full-thickness
lesions of the knee cartilage in adults, as well as Ocugen’s intention to begin
dosing in Cohort 2 of the OCU400 clinical trial this month. Such statements are
subject to numerous important factors, risks, and uncertainties that may cause
actual events or results to differ materially from our current expectations.
These and other risks and uncertainties are more fully described in our
periodic filings with the Securities and Exchange Commission (SEC), including
the risk factors described in the section entitled “Risk Factors” in the
quarterly and annual reports that we file with the SEC. Any forward-looking
statements that we make in this press release speak only as of the date of this
press release. Except as required by law, we assume no obligation to update
forward-looking statements contained in this press release whether as a result
of new information, future events, or otherwise, after the date of this press
release.

Contact:

Tiffany Hamilton
Head of Communications
IR@ocugen.com

(Tables to follow)

OCUGEN, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands)

(Unaudited)

 

June 30, 2022

 

December 31, 2021

Assets

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

115,005

 

 

$

94,958

 

Prepaid expenses and other current assets

 

7,564

 

 

 

7,688

 

Total current assets

 

122,569

 

 

 

102,646

 

Property and equipment, net

 

3,153

 

 

 

1,164

 

Restricted cash

 

 

 

 

151

 

Other assets

 

4,366

 

 

 

1,800

 

Total assets

$

130,088

 

 

$

105,761

 

Liabilities and stockholders’ equity

 

 

 

Current liabilities

 

 

 

Accounts payable

$

5,921

 

 

$

2,312

 

Accrued expenses

 

4,103

 

 

 

4,325

 

Operating lease obligations

 

314

 

 

 

363

 

Total current liabilities

 

10,338

 

 

 

7,000

 

Non-current liabilities

 

 

 

Operating lease obligations, less current portion

 

3,892

 

 

 

1,231

 

Long term debt, net

 

1,750

 

 

 

1,712

 

Total liabilities

 

15,980

 

 

 

9,943

 

Stockholders’ equity

 

 

 

Convertible preferred stock

 

1

 

 

 

1

 

Common stock

 

2,163

 

 

 

1,995

 

Treasury stock

 

(48

)

 

 

(48

)

Additional paid-in capital

 

281,139

 

 

 

225,537

 

Accumulated other comprehensive income

 

10

 

 

 

 

Accumulated deficit

 

(169,157

)

 

 

(131,667

)

Total stockholders’ equity

 

114,108

 

 

 

95,818

 

Total liabilities and stockholders’ equity

$

130,088

 

 

$

105,761

 

 

OCUGEN, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

 

Three months ended June 30,

 

Six months ended June 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Operating expenses

 

 

 

 

 

 

 

Research and development

$

9,007

 

 

$

18,853

 

 

$

16,922

 

 

$

21,725

 

General and administrative

 

10,558

 

 

 

6,757

 

 

 

20,677

 

 

 

10,942

 

Total operating expenses

 

19,565

 

 

 

25,610

 

 

 

37,599

 

 

 

32,667

 

Loss from operations

 

(19,565

)

 

 

(25,610

)

 

 

(37,599

)

 

 

(32,667

)

Other income (expense), net

 

94

 

 

 

(342

)

 

 

109

 

 

 

(362

)

Net loss

$

(19,471

)

 

$

(25,952

)

 

$

(37,490

)

 

$

(33,029

)

Shares used in calculating net loss per common share — basic and diluted

 

215,862,977

 

 

 

195,572,189

 

 

 

210,806,330

 

 

 

190,960,775

 

Net loss per share of common stock — basic and diluted

$

(0.09

)

 

$

(0.13

)

 

$

(0.18

)

 

$

(0.17

)

 


DLH Holdings (DLHC) – A Future Looking Brighter

Thursday, August 04, 2022

DLH Holdings (DLHC)
A Future Looking Brighter

DLH delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,300 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit www.DLHcorp.com.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

3Q Results. Ex FEMA revenue totaled $71.6 million, up 16.2% from $61.6 million in 3Q21. Ex FEMA, DLH would have reported net income of $3.1 million, or $0.22 per share compared to $2.9 million, or $0.21 per diluted share last year. Ex FEMA EBITDA would be at $8.4 million versus $7.0 million the previous year. We had projected revenue of $67 million, EPS of $0.23, and EBITDA of $7 million.

Base Business Continues to Thrive. DLH continues to have growth in the base business. Revenue segments increased for the Company, like the Company’s VA ($33.3 million from $27.5 million) and HHS ($27.7 million from $23.2 million) business. This is further indication of a rise in demand for DLH’s services….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Noble on the Road: Great Lakes Dredge & Dock Corporation (GLDD) Investor Day



Noble on the Road Presents: Great Lakes Dredge & Dock Corporation Investor Day

Noble Capital Markets is hosting an investor day with Great Lakes Dredge & Dock for the New York financial community on Tuesday, September 13th. CEO Lasse Petterson and CFO Scott Kornblau will present and answer questions. This is a no cost event for investors to get to know the company and management.

Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) is a leading provider of dredging services in the United States specializing in projects that help improve and protect our nation’s infrastructure and coastlines. With a robust portfolio of major dredging projects, the company brings extensive experience and a strong safety record.

Noble senior analyst Joe Gomes follows the company and has an Outperform rating with a $17.05 price target.

To learn more about Great Lakes Dredge & Dock, click here. The research is complimentary to you.

Yes, I want to meet Great Lakes Dredge & Dock

For more information on this, and other upcoming roadshows, contact:

Barbara Cohen
Managing Director, Investor Outreach & Distribution
Noble Capital Markets, Inc. Direct – (212) 863-3225
bcohen@noblecapitalmarkets.com

Release – Kratos Reports Second Quarter 2022 Financial Results



Kratos Reports Second Quarter 2022 Financial Results

Research, News, and Market Data on Kratos Defense & Security Solutions

SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, today reported its second quarter 2022 financial results. For the second quarter of 2022, Kratos reported Revenues of $224.2 million, Operating Loss of $1.9 million, Net Loss of $4.7 million, Adjusted EBITDA of $17.7 million and a book to bill ratio of 1.2 to 1.0.   Included in Net Loss is a $5.5 million litigation settlement related charge resulting from the resolution of a dispute with an international customer in our Unmanned Systems segment, which contractual arrangement was entered into in March 2011, prior to Kratos’ acquisition of CEi (Composite Engineering Inc.).

Second quarter 2022 Operating Loss includes non-cash stock compensation expense of $6.3 million, and Company-funded Research and Development expense of $9.2 million, reflecting significant ongoing development efforts being made, including in our Space and   Satellite business to develop our virtual, software-based OpenSpace ground station solution.

Kratos reported a second quarter 2022 GAAP loss per share of $0.04, which includes the $5.5 million litigation settlement related charge noted above, compared to Net Income of $1.1 million and GAAP EPS income of $0.01 for the second quarter of 2021. Adjusted EPS was $0.07 for the second quarter of 2022, compared to $0.06 for the second quarter of 2021. Kratos has approximately $235 million of net operating loss carryforwards, which are expected to substantially shield the Company from paying future cash income taxes.   

Second quarter 2022 Revenues of $224.2 million, which increased $19.1 million, or 9.3 percent, from second quarter 2021 Revenues of $205.1 million, were adversely impacted by continuing and increased supply chain disruptions and increased material costs, COVID-related employee absenteeism and increased challenges and costs associated with hiring, obtaining and retaining qualified employees, which resulted in approximately $14.5 million of second quarter 2022 revenues being deferred into future periods, with approximately $2.9 million of associated operating income, including increased inflationary costs.    Second quarter 2022 revenues include an aggregate contribution of $21.5 million from the recent acquisitions of Cosmic Advanced Engineered Solutions, Inc. (Cosmic AES), CTT, Inc., (CTT), and the Engineering Division of Southern Research (SRE), offset by reductions in our Training Solutions business of $8.6 million as compared to the second quarter 2021 revenues, including the previously reported loss of an international training services contract which accounted for approximately $4.5 million of the reduction as well as the completion of certain large training system programs. On a proforma basis, excluding the impact of the Training Solutions business, revenues grew organically 3.2% in the second quarter of 2022 as compared to the second quarter of 2021.

Second quarter 2022 Cash Flow Used in Operations was $21.6 million, with the use including increases in receivables of $27.1 million primarily related to future milestone and other contractual payments and an increase of inventory balances of $10.5 million, primarily in our Unmanned Systems, Microwave Products and C5ISR businesses in anticipation of expected significant ramps in production in the second half of the year and to increase stock inventory levels and advance buys in larger lot sizes to gain pricing benefits where possible, to mitigate the impact of supply chain disruptions and price increases. Free Cash Flow Used in Operations was $32.7 million, after funding $11.1 million of capital expenditures, including in our high growth Unmanned Systems, Space, Satellite and Cyber and Turbine Technologies business areas.

For the second quarter of 2022, Kratos’ Unmanned Systems Segment (KUS) generated Revenues of $56.4 million, as compared to $60.3 million in the second quarter of 2021. KUS Operating Loss was $5.0 million in the second quarter of 2022, which included the $5.5 million litigation settlement related charge discussed above. Excluding the impact of the litigation settlement related charge, Operating Income was $0.5 million, compared to $4.1 million in the second quarter of 2021, reflecting a less favorable mix of revenues, including an increase in development programs which typically generate lower margins, an increase in SG&A costs of approximately $0.9 million resulting primarily from increased headcount, an increase of R&D expenses of approximately $1.3 million and increases in supply chain and employee related costs.

Excluding the litigation settlement charge, KUS Adjusted EBITDA for the second quarter of 2022 was $2.9 million, compared to second quarter 2021 Adjusted EBITDA of $6.9 million, reflecting increases in certain development programs which typically generate lower margins and increases in SG&A, R&D, supply chain related and employee costs.
        

KUS’s book-to-bill ratio for the second quarter of 2022 was 0.5 to 1.0 and 1.1 to 1.0 for the last twelve months ended June 26, 2022, with bookings of $242.6 million for the twelve months ended June 26, 2022.   Total backlog for KUS at the end of the second quarter of 2022 was $203.3 million compared to $230.5 million at the end of the first quarter of 2022.

For the second quarter of 2022, Kratos’ Government Solutions Segment (KGS) reported Revenues of $167.8 million, compared to Revenues of $144.8 million in the second quarter of 2021. The increased revenues include the aggregate contribution of approximately $21.5 million from the recently acquired Cosmic AES, CTT and SRE, offset by a reduction of $8.6 million in our Training Solutions business, including the loss of an international training contract, continued and increased supply chain, COVID and employee sourcing and retention disruptions, which resulted in second quarter 2022 KGS revenues of approximately $13.9 million being deferred into future periods.    On a proforma basis, excluding the Training Solutions business, KGS revenues grew organically 7.7 percent or $10.2 million, from $132.3 million in the second quarter of 2021 to $142.5 million in the second quarter of 2022.

KGS reported operating income of $9.5 million in the second quarter of 2022, compared to $5.9 million in the second quarter of 2021, primarily reflecting a more favorable revenue mix, offset partially by increased costs related to the supply chain and employee base.  

Kratos’ Space, Satellite and Cyber business generated Revenues of $88.5 million in the second quarter of 2022, compared to $67.5 million in the second quarter of 2021. Excluding revenues generated of $15.0 million from the recent Cosmic AES acquisition, revenues for our Space, Satellite and Cyber business grew organically 8.9 percent in the second quarter of 2022.

Second quarter 2022 KGS Adjusted EBITDA was $14.8 million, compared to second quarter 2021 KGS Adjusted EBITDA of $10.7 million, reflecting a more favorable mix of revenues, including in our Space, Satellite and Cyber and Turbine Technologies businesses.

For the second quarter of 2022, KGS reported a book-to-bill ratio of 1.4 to 1.0, with a book to bill ratio of 1.2 to 1.0 for the twelve months ended June 26, 2022, and bookings of $713.9 million for the twelve months ended June 26, 2022.   Included in KGS is Kratos’ Space, Satellite and Cyber business, which reported a book to bill ratio of 1.7 to 1.0 for the second quarter of 2022, and a book to bill ratio of 1.2 to 1.0 for the twelve months ended June 26, 2022. Bookings for the Space, Satellite and Cyber business for the last twelve months ended June 26, 2022, were $371.1 million. KGS’s total backlog at the end of the second quarter of 2022 was $846.9 million, as compared to $751.6 million at the end of the first quarter of 2022.

For the second quarter of 2022, Kratos reported consolidated bookings of $261.0 million and a book-to-bill ratio of 1.2 to 1.0, with consolidated bookings of $956.5 million and a book-to-bill ratio of 1.1 to 1.0 for the last twelve months ended June 26, 2022. Backlog on June 26, 2022 was $1.05 billion, as compared to $982.1 million at March 27, 2022, and Kratos’ bid and proposal pipeline was $9.9 billion at June 26, 2022, as compared to $9.4 billion at March 27, 2022.   Backlog at June 26, 2022 was comprised of funded backlog of $713.6 million and unfunded backlog of $336.6 million.

Eric DeMarco, Kratos’ President and CEO, said, “Kratos’ second quarter execution was solid in a challenging environment, including revenues of $224 million, Adjusted EBITDA of $17.7 million, a 1.2 to 1.0 book to bill ratio and a current opportunity pipeline of over $9 billion. We have now received each of the three important, large new satellite related program awards we discussed in our Q1 2022 report, including contracts with Blue Halo and Intelsat, which we believe position Kratos for future organic growth and increased margins beginning in the second half of this year. We believe these awards are representative of the increasing customer acceptance of Kratos’ first to market, internally funded and developed, software-based OpenSpace virtualized family of products and we are now in pursuit of several additional, large, new satellite program opportunities.”

Mr. DeMarco, continued, “Since our last report to you, the Air Force announced to Congress that the Skyborg Vanguard program, which includes Kratos’ Valkyrie, is now planned to be a Program of Record in 2023 and transition to acquisition. Additionally, Kratos’ tactical drone business continues to progress, including recent successful flights at the Burns Flat, Oklahoma range and other locations, and we are expecting to receive certain new tactical drone related contract awards in the second half of this year, including as related to Valkyrie.   Also importantly, the Air Force recently announced that the Golden Horde Vanguard Program, which Kratos is also supporting, is now also slated to become a Program of Record in 2023, which includes networked, collaborative and autonomous munitions and drones.”     

Mr. DeMarco concluded, “Based on important recent events and communications, we continue to believe that the global security environment and requirement for affordable, reusable, disposable and attritable high performance jet drones has never been stronger and is increasing. We view Kratos’ family of Made in America, demonstrated low-cost, runway independent, Collaborative Combat Aircraft, that have been flying with manned fighter aircraft since 2015, and are not concepts, power points or video presentations that are years away from reality, along with active Kratos serial production lines that can provide Affordable Mass now, are important differentiators for our Country, our customers and our Company.”

Financial Guidance
Our third quarter and Fiscal Year 2022 financial guidance we are providing today includes our current forecasted business mix, and our assumptions related to the expected continuing impact of: employee absenteeism, employee sourcing, hiring and retention; manufacturing, production and supply chain disruptions; parts shortages and related significant cost and price increases, including for employees, materials and components; travel restrictions and other COVID-19 related items that have and continue to impact the industry and Kratos.   The growth expected in the fourth quarter of 2022 is largely driven by the forecasted execution and delivery schedules of 5 new programs, 4 of which have already been awarded: the three satellite program awards, GBSD and an expected Valkyrie award from a new customer.        

The revised full Fiscal Year 2022 financial guidance reflects the expected revenue growth, including the impact of the recent SRE acquisition, as well as expected organic revenue growth driven by our recent bookings and backlog. Since our contract mix is predominantly firm fixed price, we are contractually obligated to absorb the impact of significant inflationary factors until we are able to include our revised costs in new contracts or the exercise of contractual options, which is reflected in our revised Fiscal Year 2022 Adjusted EBITDA guidance.

$M

Q322

FY22

Revenues

$220 – $230

$890 – $930

R&D

$9 – $10

$35 – $38

Operating Income

$0 – $3

$13 – $18

Depreciation

$7

$24 – $25

Amortization

$3

$8 – $9

Stock Based Compensation

$6 – $7

$25 – $26

Adjusted EBITDA

$16 – $20

$80 – $85

Operating Cash Flow

 

$15 – $25

Capital Expenditures

 

$45 – $55

Free Cash Flow Use

 

($30 – $40)

 

Throughout the second quarter of 2022, we continued to experience the effects of COVID–19, including on our employees, consultants, vendors, suppliers, customers, etc. We have assumed that these COVID–19 related impacts to our business, which significantly impacted our fiscal first and second quarters of 2022 and continue to impact our third quarter, will continue at least through the end of calendar 2022. Our previous assumption was that COVID-19 related impacts would begin to subside beginning in the third fiscal quarter and continue to improve throughout the second half of our fiscal year 2022.

We currently estimate that COVID, supply chain, work force and inflation related issues, including the availability and increased costs of certain raw materials and related components and materials, a lack of capacity at mills supporting Kratos’ hardware programs, the availability and significant increased costs to obtain and the ability to retain an experienced skilled workforce will continue to impact our financial performance throughout 2022. We expect these issues to impact our third quarter 2022 Revenues by approximately $10 to $14 million and Adjusted EBITDA by approximately $3 to $5 million, respectively. We also currently estimate these issues to impact our full fiscal year 2022 Revenues by approximately $22 to $26 million and Adjusted EBITDA by approximately $10 to $13 million, respectively. We will provide future updates as appropriate.  

The forecasted financial trajectory in the second half of 2022 reflects the expected mix of revenues, including the expected timing of software product deliveries in our Space, Satellite and Cyber business, based upon the forecasted order flow and roll out of our new OpenSpace solution, and contract awards we have recently received or that we have been informed we will receive, with deliveries expected to occur predominantly in the fourth quarter of 2022 based upon current program execution plans.  

Forecasted third quarter 2022 and fiscal year 2022 Operating Income and Adjusted EBITDA also reflect the expected mix of development-type contracts and expected investments, including in our Space, Satellite and Cyber, Unmanned Systems, C5ISR, Turbine Technologies and Rocket System businesses, where we have received, have been informed that we will receive, or are pursuing or expect to receive several new contract awards.   Kratos’ fiscal year 2022 forecasted Revenues also include the final projected impact of the 2021 loss of a large international training contract, which contributed approximately $13.0 million to the Company’s fiscal year 2021 first and second quarter Revenues and include the estimated contribution from the recently closed CTT, Cosmic AES and SRE acquisitions.  

Management will discuss the Company’s second quarter 2022 financial results, as well as its third quarter and full year 2022 guidance on a conference call beginning at 2:00 p.m. Pacific (5:00 p.m. Eastern) today. The call will be available at www.kratosdefense.com. Participants may register for the call at 
https://register.vevent.com/register/BId7480930af214120a135751b6240fd74. While not required, it is recommended you join 10 minutes prior to the event start. Instructions are provided to ensure the necessary audio applications are downloaded and installed. Users can obtain these programs at no charge. For those who cannot access the live broadcast, a replay will be available on Kratos’ website.

About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms, and systems for United States National Security related customers, allies, and commercial enterprises.  Kratos is changing the way breakthrough technologies for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research, and streamlined development processes.  At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training and combat systems and next generation turbo jet and turbo fan engine development. For more information go to www.kratosdefense.com.

Notice Regarding Forward-Looking Statements
This news release contains certain forward-looking statements that involve risks and uncertainties, including, without limitation, express or implied statements concerning the Company’s expectations regarding its future financial performance, including the Company’s expectations for its third quarter and full year 2022 revenues, R&D, operating income, depreciation, amortization, stock based compensation expense, and Adjusted EBITDA, and full year 2022 operating cash flow, capital expenditures and other investments, and free cash flow use, the Company’s future growth trajectory and ability to achieve improved revenue mix and profit in certain of its business segments and the expected timing of such improved revenue mix and profit, the Company’s expectation of ramp on projects and that investments in its business will result in an increase in the Company’s market share and total addressable market and position the Company for significant future organic growth, profitability, cash flow and an increase in shareholder value, the Company’s bid and proposal pipeline, demand for its products and services, including the Company’s alignment with today’s National Security requirements, ability to successfully compete in the tactical unmanned aerial system area and expected new customer awards, including the magnitude and timing of funding and the future opportunity associated with such awards, and expected contract awards related to the Company’s Skyborg Vanguard program, Golden Horde Vanguard program and other new tactical unmanned programs, performance of key contracts and programs, including the timing of production and demonstration related to certain of the Company’s contracts and product offerings, the impact of the Company’s restructuring efforts and cost reduction measures, including its ability to improve profitability and cash flow in certain business units as a result of these actions and to achieve financial leverage on fixed administrative costs, benefits to be realized from the Company’s net operating loss carry forwards, the availability and timing of government funding for the Company’s offerings, including the strength of the future funding environment, the short-term delays that may occur as a result of Continuing Resolutions or delays in DoD budget approvals, timing of LRIP and full rate production related to the Company’s unmanned aerial target system offerings, as well as the level of recurring revenues expected to be generated by these programs once they achieve full rate production, market and industry developments, and the current estimated impact of COVID-19 and employee absenteeism, supply chain disruptions, availability of an experienced skilled workforce, inflation and increased costs, and delays on our financial projections, industry, business and operations, including projected growth. Such statements are only predictions, and the Company’s actual results may differ materially from the results expressed or implied by these statements. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Factors that may cause the Company’s results to differ include, but are not limited to: risks to our business and financial results related to the reductions and other spending constraints imposed on the U.S. Government and our other customers, including as a result of sequestration and extended continuing resolutions, the Federal budget deficit and Federal government shut-downs; risks of adverse regulatory action or litigation; risks associated with debt leverage and cost savings and cash flow improvements expected as a result of the refinancing of our Senior Notes; risks that our cost-cutting initiatives will not provide the anticipated benefits; risks that changes, cutbacks or delays in spending by the U.S. DoD may occur, which could cause delays or cancellations of key government contracts; risks of delays to or the cancellation of our projects as a result of protest actions submitted by our competitors; risks that changes may occur in Federal government (or other applicable) procurement laws, regulations, policies and budgets; risks of the availability of government funding for the Company’s products and services due to performance, cost growth, or other factors, changes in government and customer priorities and requirements (including cost-cutting initiatives, the potential deferral of awards, terminations or reduction of expenditures to respond to the priorities of Congress and the Administration, or budgetary cuts resulting from Congressional committee recommendations or automatic sequestration under the Budget Control Act of 2011, as amended); risks that the UAS and UGS markets do not experience significant growth; risks that products we have developed or will develop will become programs of record; risks that we cannot expand our customer base or that our products do not achieve broad acceptance which could impact our ability to achieve our anticipated level of growth; risks of increases in the Federal government initiatives related to in-sourcing; risks related to security breaches, including cyber security attacks and threats or other significant disruptions of our information systems, facilities and infrastructures; risks related to our compliance with applicable contracting and procurement laws, regulations and standards; risks related to the new DoD Cybersecurity Maturity Model Certification (CMMC); risks related to contract performance; risks related to failure of our products or services; risks associated with our subcontractors’ or suppliers’ failure to perform their contractual obligations, including the appearance of counterfeit or corrupt parts in our products; changes in the competitive environment (including as a result of bid protests); failure to successfully integrate acquired operations and competition in the marketplace, which could reduce revenues and profit margins; risks that potential future goodwill impairments will adversely affect our operating results; risks that anticipated tax benefits will not be realized in accordance with our expectations; risks that a change in ownership of our stock could cause further limitation to the future utilization of our net operating losses; risks that we may be required to record valuation allowances on our net operating losses which could adversely impact our profitability and financial condition; risks that the current economic environment will adversely impact our business; currently unforeseen risks associated with COVID-19 and risks related to natural disasters or severe weather. These and other risk factors are more fully discussed in the Company’s Annual Report on Form 10-K for the period ended December 26, 2021, and in our other filings made with the Securities and Exchange Commission.

Note Regarding Use of Non-GAAP Financial Measures and Other
Performance Metrics

This news release contains non-GAAP financial measures, including Adjusted earnings per share (computed using income from continuing operations before income taxes, excluding income (loss) from discontinued operations, excluding income (loss) attributable to non-controlling interest, excluding depreciation, amortization of intangible assets, amortization of capitalized contract and development costs, stock-based compensation expense, acquisition and restructuring related items and other, which includes, but is not limited to, legal related items and foreign transaction gains and losses, less the estimated impact to income taxes) and including Adjusted EBITDA (which includes net income (loss) attributable to noncontrolling interest and excludes, among other things, losses and gains from discontinued operations, acquisition and restructuring related items, stock compensation expense, foreign transaction gains and losses, and the associated margin rates). Additional non-GAAP financial measures include Free Cash Flow from Operations computed as Cash Flow from Operations less Capital Expenditures and Adjusted EBITDA related to our KUS and KGS businesses. Kratos believes this information is useful to investors because it provides a basis for measuring the Company’s available capital resources, the actual and forecasted operating performance of the Company’s business and the Company’s cash flow, excluding non-recurring items and non-cash items that would normally be included in the most directly comparable measures calculated and presented in accordance with GAAP. The Company’s management uses these non-GAAP financial measures, along with the most directly comparable GAAP financial measures, in evaluating the Company’s actual and forecasted operating performance, capital resources and cash flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and investors should carefully evaluate the Company’s financial results calculated in accordance with GAAP and reconciliations to those financial results. In addition, non-GAAP financial measures as reported by the Company may not be comparable to similarly titled amounts reported by other companies. As appropriate, the most directly comparable GAAP financial measures and information reconciling these non-GAAP financial measures to the Company’s financial results prepared in accordance with GAAP are included in this news release.

Another Performance Metric the Company believes is a key performance indicator in our industry is our Book to Bill Ratio as it provides investors with a measure of the amount of bookings or contract awards as compared to the amount of revenues that have been recorded during the period and provides an indicator of how much of the Company’s backlog is being burned or utilized in a certain period. The Book to Bill Ratio is computed as the number of bookings or contract awards in the period divided by the revenues recorded for the same period. The Company believes that the rolling or last twelve months’ Book to Bill Ratio is meaningful since the timing of quarter-to-quarter bookings can vary.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687

investor@kratosdefense.com 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Condensed Consolidated
Statements of Operations

 

 

(in millions, except per share
data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service revenues

 

$

78.8

 

 

$

58.0

 

 

$

146.7

 

 

$

115.3

 

 

 

Product sales

 

 

145.4

 

 

 

147.1

 

 

 

273.7

 

 

 

284.0

 

 

 

Total revenues

 

 

224.2

 

 

 

205.1

 

 

 

420.4

 

 

 

399.3

 

 

 

Cost of service revenues

 

 

56.2

 

 

 

41.3

 

 

 

106.1

 

 

 

83.8

 

 

 

Cost of product sales

 

 

110.2

 

 

 

111.8

 

 

 

204.6

 

 

 

212.5

 

 

 

Total costs

 

 

166.4

 

 

 

153.1

 

 

 

310.7

 

 

 

296.3

 

 

 

Gross profit – service revenues

 

 

22.6

 

 

 

16.7

 

 

 

40.6

 

 

 

31.5

 

 

 

Gross profit – product sales

 

 

35.2

 

 

 

35.3

 

 

 

69.1

 

 

 

71.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Total gross profit

 

 

57.8

 

 

 

52.0

 

 

 

109.7

 

 

 

103.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

41.6

 

 

 

35.6

 

 

 

81.9

 

 

 

70.9

 

 

 

Acquisition and restructuring related items and other

 

 

6.0

 

 

 

0.3

 

 

 

6.6

 

 

 

0.5

 

 

 

Research and development expenses

 

 

9.2

 

 

 

10.2

 

 

 

18.4

 

 

 

18.2

 

 

 

Depreciation

 

 

1.3

 

 

 

1.4

 

 

 

2.6

 

 

 

2.6

 

 

 

Amortization of intangible assets

 

 

1.6

 

 

 

1.2

 

 

 

3.3

 

 

 

2.6

 

 

 

     Operating income (loss)

 

 

(1.9

)

 

 

3.3

 

 

 

(3.1

)

 

 

8.2

 

 

 

Interest expense, net

 

 

(2.9

)

 

 

(5.7

)

 

 

(8.8

)

 

 

(11.6

)

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

(13.0

)

 

 

 

 

 

Other income, net

 

 

 

 

 

 

 

 

0.1

 

 

 

0.2

 

 

 

Loss from continuing operations before income taxes

 

 

(4.8

)

 

 

(2.4

)

 

 

(24.8

)

 

 

(3.2

)

 

 

Provision (benefit) for income taxes from continuing operations

 

 

0.5

 

 

 

(3.6

)

 

 

(3.8

)

 

 

(6.3

)

 

 

Income (loss) from continuing operations

 

 

(5.3

)

 

 

1.2

 

 

 

(21.0

)

 

 

3.1

 

 

 

Income (loss) from discontinued operations, net of income taxes

 

 

0.9

 

 

 

(0.3

)

 

 

0.7

 

 

 

(0.3

)

 

 

     Net income (loss)

 

 

(4.4

)

 

 

0.9

 

 

 

(20.3

)

 

 

2.8

 

 

 

     Less: Net income (loss) attributable to noncontrolling interest

 

 

0.3

 

 

(0.2

)

 

 

0.3

 

 

 

(0.2

)

 

 

     Net income (loss) attributable to Kratos

 

$

(4.7

)

 

$

1.1

 

 

$

(20.6

)

 

$

3.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per common share attributable to Kratos:

 

 

 

 

 

 

 

 

 

 

     Income (loss) from continuing operations

 

$

(0.04

)

 

$

0.01

 

 

$

(0.17

)

 

$

0.02

 

 

 

     Income (loss) from discontinued operations

 

 

 

 

 

 

 

 

0.01

 

 

 

 

 

 

     Net income (loss)

 

 

(0.04

)

 

$

0.01

 

 

$

(0.16

)

 

$

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted income (loss) per common share attributable to Kratos:

 

 

 

 

 

 

 

 

 

 

     Income (loss) from continuing operations

 

$

(0.04

)

 

$

0.01

 

 

$

(0.17

)

 

$

0.02

 

 

 

     Income (loss) from discontinued operations

 

 

 

 

 

 

 

 

0.01

 

 

 

 

 

 

     Net income (loss)

 

$

(0.04

)

 

$

0.01

 

 

$

(0.16

)

 

$

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

     Basic weighted average common shares outstanding

 

 

126.4

 

 

 

124.7

 

 

 

126.2

 

 

 

124.4

 

 

 

     Diluted weighted average common shares outstanding

 

 

126.4

 

 

 

127.7

 

 

 

126.2

 

 

 

127.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA (1)

 

$

17.7

 

 

$

17.6

 

 

$

31.5

 

 

$

35.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited Reconciliation of GAAP to Non-GAAP Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note: (1) Adjusted EBITDA is a non-GAAP measure defined as GAAP net income (loss) attributable to Kratos adjusted for net income (loss)

 

 

 

 

attributable to noncontrolling interest, income (loss) from discontinued operations, net interest expense, provision (benefit) for income taxes, depreciation and

 

 

amortization expense of intangible assets, amortization of capitalized contract and development costs, stock-based compensation,

 

 

 

 

 

 

acquisition and restructuring related items and other, and foreign transaction gain (loss).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA as calculated by us may be calculated differently than Adjusted EBITDA for other companies. We have provided

 

 

 

 

 

 

Adjusted EBITDA because we believe it is a commonly used measure of financial performance in comparable companies and is provided to

 

 

 

 

help investors evaluate companies on a consistent basis, as well as to enhance understanding of our operating results. Adjusted EBITDA

 

 

 

 

should not be construed as either an alternative to net income or as an indicator of our operating performance or an alternative to cash flows

 

 

 

 

as a measure of liquidity. The adjustments to calculate this non-GAAP financial measure and the basis for such adjustments are outlined below.

 

 

 

 

Please refer to the following table below that reconciles GAAP net income (loss) to Adjusted EBITDA.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The adjustments to calculate this non-GAAP financial measure, and the basis for such adjustments, are outlined below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income and interest expense, net. The Company receives interest income on investments and incurs interest expense on loans, capital leases and

 

 

other financing arrangements, including the amortization of issue discounts and deferred financing costs. These amounts may vary from period to period

 

 

due to changes in cash and debt balances.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes. The Company’s tax expense can fluctuate materially from period to period due to tax adjustments that may not be directly related to

 

 

 

 

underlying operating performance or to the current period of operations and may not necessarily reflect the impact of utilization of our NOLs.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation. The Company incurs depreciation expense (recorded in cost of revenues and in operating expenses) related to capital assets purchased,

 

 

 

 

leased or constructed to support the ongoing operations of the business. The assets are recorded at cost or fair value and are depreciated over the estimated

 

 

useful lives of individual assets.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangible assets. The Company incurs amortization of intangible expense related to acquisitions it has made. These intangible assets are

 

 

valued at the time of acquisition and are amortized over the estimated useful lives.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of capitalized contract and development
costs. 
The Company incurs amortization of previously capitalized software development and non-

 

 

 

recurring engineering costs related to certain targets in its Unmanned Systems and ballistic missile target businesses as these units are sold.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense. The Company incurs expense related to stock-based compensation included in its GAAP presentation of selling,

 

 

 

 

general and administrative expense. Although stock-based compensation is an expense of the Company and viewed as a form of compensation, these

 

 

 

 

expenses vary in amount from period to period, and are affected by market forces that are difficult to predict and are not within the control of management,

 

 

such as the market price and volatility of the Company’s shares, risk-free interest rates and the expected term and forfeiture rates of the awards.

 

 

 

 

Management believes that exclusion of these expenses allows comparison of operating results to those of other companies that disclose non-GAAP

 

 

 

 

financial measures that exclude stock-based compensation.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign transaction (gain) loss. The Company incurs transaction gains and losses related to transactions with foreign customers in currencies other than

 

 

 

the U.S. dollar. In addition, certain intercompany transactions can give rise to realized and unrealized foreign currency gains and losses.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition and transaction related items. The Company incurs transaction related costs, such as legal and accounting fees and other expenses, related to

 

 

acquisitions and divestiture activities. Management believes these items are outside the normal operations of the Company’s business and are not

 

 

 

 

indicative of ongoing operating results.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring costs. The Company incurs restructuring costs for cost reduction actions which include employee termination costs,

 

 

 

 

 

 

facility shut-down related costs and remaining lease commitment costs for excess or exited facilities. Management believes that these costs are not

 

 

 

 

indicative of ongoing operating results as they are either non-recurring and/or not expected when full capacity and volumes are achieved.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Legal related items. The Company incurs costs related to pending legal settlements and other legal related matters. Management believes

 

 

 

 

these items are outside the normal operations of the Company’s business and are not indicative of ongoing operating results.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA is a non-GAAP financial measure and should not be considered in isolation or as a substitute for financial information provided in

 

 

 

 

accordance with GAAP. This non-GAAP financial measure may not be computed in the same manner as similarly titled measures used by other

 

 

 

 

companies. The Company expects to continue to incur expenses similar to the Adjusted EBITDA financial adjustments described above, and investors

 

 

 

 

should not infer from the Company’s presentation of this non-GAAP financial measure that these costs are unusual, infrequent, or non-recurring.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net income (loss) attributable to Kratos to Adjusted EBITDA is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Kratos

 

$

(4.7

)

 

$

1.1

 

 

$

(20.6

)

 

$

3.0

 

 

 

Loss (income) from discontinued operations, net of income taxes

 

 

(0.9

)

 

 

0.3

 

 

 

(0.7

)

 

 

0.3

 

 

 

Interest expense, net

 

 

2.9

 

 

 

5.7

 

 

 

8.8

 

 

 

11.6

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

13.0

 

 

 

 

 

 

Provision (benefit) for income taxes from continuing operations

 

 

0.5

 

 

 

(3.6

)

 

 

(3.8

)

 

 

(6.3

)

 

 

Depreciation (including cost of service revenues and product sales)

 

 

5.3

 

 

 

5.8

 

 

 

10.6

 

 

 

10.7

 

 

 

Stock-based compensation

 

 

6.3

 

 

 

6.6

 

 

 

13.3

 

 

 

12.8

 

 

 

Foreign transaction loss

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

 

 

0.2

 

 

 

Amortization of intangible assets

 

 

1.6

 

 

 

1.2

 

 

 

3.3

 

 

 

2.6

 

 

 

Amortization of capitalized contract and development costs

 

 

0.3

 

 

 

0.3

 

 

 

0.6

 

 

 

0.5

 

 

 

Acquisition and restructuring related items and other

 

 

6.0

 

 

 

0.3

 

 

 

6.6

 

 

 

0.5

 

 

 

Plus: Net income (loss) attributable to noncontrolling interest

 

 

0.3

 

 

 

(0.2

)

 

 

0.3

 

 

 

(0.2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

17.7

 

 

$

17.6

 

 

$

31.5

 

 

$

35.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of acquisition and restructuring related items and other included in Adjusted EBITDA:

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Acquisition and transaction related items

 

$

0.1

 

 

$

0.1

 

 

$

0.4

 

 

$

0.3

 

 

 

Restructuring costs

 

 

0.2

 

 

 

0.2

 

 

 

0.3

 

 

 

0.2

 

 

 

Legal related items

 

 

5.7

 

 

 

 

 

 

5.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

6.0

 

 

$

0.3

 

 

$

6.6

 

 

$

0.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Segment Data

 

 

(in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

 

Unmanned Systems

 

$

56.4

 

 

$

60.3

 

 

$

109.0

 

 

$

116.2

 

 

 

Kratos Government Solutions

 

 

167.8

 

 

 

144.8

 

 

 

311.4

 

 

 

283.1

 

 

 

Total revenues

 

$

224.2

 

 

$

205.1

 

 

$

420.4

 

 

$

399.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

 

 

 

 

 

 

 

 

Unmanned Systems

 

$

(5.0

)

 

$

4.1

 

 

$

(4.5

)

 

$

8.3

 

 

 

Kratos Government Solutions

 

 

9.5

 

 

 

5.9

 

 

 

15.1

 

 

 

13.0

 

 

 

Unallocated corporate expense, net

 

 

(6.4

)

 

 

(6.7

)

 

 

(13.7

)

 

 

(13.1

)

 

 

Total operating income (loss)

 

$

(1.9

)

 

$

3.3

 

 

$

(3.1

)

 

$

8.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note: Unallocated corporate expense, net includes costs for certain stock-based compensation programs (including stock-based compensation costs for stock options, employee stock purchase plan and restricted stock units), the effects of items not considered part of management’s evaluation of segment operating performance, and acquisition and restructuring related items, corporate costs not allocated to the segments, legal related items, and other miscellaneous corporate activities.

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Segment Operating Income (Loss) to Adjusted EBITDA is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Unmanned Systems

 

 

 

 

 

 

 

 

 

 

   Operating income (loss)

 

$

(5.0

)

 

$

4.1

 

 

$

(4.5

)

 

$

8.3

 

 

 

   Other income

 

 

 

 

 

 

 

 

0.1

 

 

 

0.1

 

 

 

   Depreciation

 

 

1.7

 

 

 

2.2

 

 

 

3.3

 

 

 

3.8

 

 

 

   Amortization of intangible assets

 

 

0.2

 

 

 

0.3

 

 

 

0.5

 

 

 

0.6

 

 

 

   Amortization of capitalized contract and development costs

 

 

0.3

 

 

 

0.3

 

 

 

0.6

 

 

 

0.5

 

 

 

   Acquisition and restructuring related items and other

 

 

5.7

 

 

 

 

 

 

5.9

 

 

 

 

 

 

      Adjusted EBITDA

 

$

2.9

 

 

$

6.9

 

 

$

5.9

 

 

$

13.3

 

 

 

  % of revenue

 

 

5.1

%

 

 

11.4

%

 

 

5.4

%

 

 

11.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Government Solutions

 

 

 

 

 

 

 

 

 

 

   Operating income

 

$

9.5

 

 

$

5.9

 

 

$

15.1

 

 

$

13.0

 

 

 

   Other income

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

 

 

0.3

 

 

 

   Depreciation

 

 

3.6

 

 

 

3.6

 

 

 

7.3

 

 

 

6.9

 

 

 

   Amortization of intangible assets

 

 

1.4

 

 

 

0.9

 

 

 

2.8

 

 

 

2.0

 

 

 

   Acquisition and restructuring related items and other

 

 

0.2

 

 

 

0.2

 

 

 

0.3

 

 

 

0.2

 

 

 

      Adjusted EBITDA

 

$

14.8

 

 

$

10.7

 

 

$

25.6

 

 

$

22.4

 

 

 

  % of revenue

 

 

8.8

%

 

 

7.4

%

 

 

8.2

%

 

 

7.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

     Total Adjusted EBITDA

 

$

17.7

 

 

$

17.6

 

 

$

31.5

 

 

$

35.7

 

 

 

  % of revenue

 

 

7.9

%

 

 

8.6

%

 

 

7.5

%

 

 

8.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Condensed Consolidated
Balance Sheets

 

 

(in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 26,

 

December 26,

 

 

 

 

 

 

 

 

 

2022

 

 

 

2021

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

$

142.4

 

 

$

349.4

 

 

 

Accounts receivable, net

 

 

 

 

 

 

315.0

 

 

 

284.7

 

 

 

Inventoried costs

 

 

 

 

 

 

118.2

 

 

 

91.7

 

 

 

Prepaid expenses

 

 

 

 

 

 

12.2

 

 

 

9.8

 

 

 

Other current assets

 

 

 

 

 

 

36.5

 

 

 

22.5

 

 

 

Total current assets

 

 

 

 

 

 

624.3

 

 

 

758.1

 

 

 

Property, plant and equipment, net

 

 

 

 

 

 

212.2

 

 

 

168.3

 

 

 

Operating lease right-of-use assets

 

 

 

 

 

 

38.1

 

 

 

38.5

 

 

 

Goodwill

 

 

 

 

 

 

551.9

 

 

 

493.9

 

 

 

Intangible assets, net

 

 

 

 

 

 

64.9

 

 

 

43.2

 

 

 

Other assets

 

 

 

 

 

 

91.9

 

 

 

87.5

 

 

 

Total assets

 

 

 

 

 

$

1,583.3

 

 

$

1,589.5

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

 

 

 

$

58.2

 

 

$

50.4

 

 

 

Accrued expenses

 

 

 

 

 

 

36.0

 

 

 

27.2

 

 

 

Accrued compensation

 

 

 

 

 

 

50.1

 

 

 

47.3

 

 

 

Accrued interest

 

 

 

 

 

 

0.3

 

 

 

1.5

 

 

 

Billings in excess of costs and earnings on uncompleted contracts

 

 

 

 

 

 

59.2

 

 

 

58.1

 

 

 

Current portion of operating lease liabilities

 

 

 

 

 

 

10.6

 

 

 

10.1

 

 

 

Other current liabilities

 

 

 

 

 

 

12.5

 

 

 

25.7

 

 

 

Other current liabilities of discontinued operations

 

 

 

 

 

 

0.9

 

 

 

0.8

 

 

 

Total current liabilities

 

 

 

 

 

 

227.8

 

 

 

221.1

 

 

 

Long-term debt

 

 

 

 

 

 

293.8

 

 

 

296.7

 

 

 

Operating lease liabilities, net of current portion

 

 

 

 

 

 

31.5

 

 

 

32.7

 

 

 

Other long-term liabilities

 

 

 

 

 

 

82.9

 

 

 

76.2

 

 

 

Other long-term liabilities of discontinued operations

 

 

 

 

 

 

1.4

 

 

 

2.5

 

 

 

Total liabilities

 

 

 

 

 

 

637.4

 

 

 

629.2

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interest

 

 

 

 

 

 

7.8

 

 

 

15.2

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

 

 

 

 

 

1,593.1

 

 

 

1,578.9

 

 

 

Accumulated other comprehensive loss

 

 

 

 

 

 

 

 

 

0.6

 

 

 

Accumulated deficit

 

 

 

 

 

 

(655.0

)

 

 

(634.4

)

 

 

Total Kratos stockholders’ equity

 

 

 

 

 

 

938.1

 

 

 

945.1

 

 

 

Total liabilities and stockholders’ equity

 

 

 

 

 

$

1,583.3

 

 

$

1,589.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Condensed Consolidated
Statements of Cash Flows

 

 

(in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 26,

 

June 27,

 

 

 

 

 

 

 

 

 

2022

 

 

 

2021

 

 

 

Operating activities:

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

 

 

 

$

(20.3

)

 

$

2.8

 

 

 

Less: income (loss) from discontinued operations

 

 

 

 

 

 

0.7

 

 

 

(0.3

)

 

 

Income (loss) from continuing operations

 

 

 

 

 

 

(21.0

)

 

 

3.1

 

 

 

Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities from continuing operations:

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

13.9

 

 

 

13.3

 

 

 

Amortization of lease right-of-use assets

 

 

 

 

 

 

5.3

 

 

 

4.5

 

 

 

Deferred income taxes

 

 

 

 

 

 

0.4

 

 

 

(0.9

)

 

 

Stock-based compensation

 

 

 

 

 

 

13.3

 

 

 

12.8

 

 

 

Litigation related charges

 

 

 

 

 

 

5.5

 

 

 

 

 

 

Amortization of deferred financing costs

 

 

 

 

 

 

0.4

 

 

 

0.5

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

13.0

 

 

 

 

 

 

Provision for (recovery of) doubtful accounts

 

 

 

 

 

 

 

 

 

(0.2

)

 

 

Changes in assets and liabilities, net of acquisitions:

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

 

 

 

 

0.3

 

 

 

15.5

 

 

 

Unbilled receivables

 

 

 

 

 

 

(15.3

)

 

 

(7.9

)

 

 

Inventoried costs

 

 

 

 

 

 

(25.8

)

 

 

(6.8

)

 

 

Prepaid expenses and other assets

 

 

 

 

 

 

(13.2

)

 

 

(2.2

)

 

 

Operating lease liabilities

 

 

 

 

 

 

(5.5

)

 

 

(4.5

)

 

 

Accounts payable

 

 

 

 

 

 

5.6

 

 

 

5.8

 

 

 

Accrued compensation

 

 

 

 

 

 

(1.3

)

 

 

(1.8

)

 

 

Accrued expenses

 

 

 

 

 

 

7.7

 

 

 

(7.5

)

 

 

Accrued interest

 

 

 

 

 

 

(1.1

)

 

 

 

 

 

Billings in excess of costs and earnings on uncompleted contracts

 

 

 

 

 

 

1.3

 

 

 

9.6

 

 

 

Income tax receivable and payable

 

 

 

 

 

 

(6.2

)

 

 

(6.1

)

 

 

Other liabilities

 

 

 

 

 

 

(6.8

)

 

 

(5.2

)

 

 

Net cash provided by (used in) operating activities from continuing operations

 

 

 

 

 

 

(29.5

)

 

 

22.0

 

 

 

Investing activities:

 

 

 

 

 

 

 

 

 

 

Cash paid for acquisitions, net of cash acquired

 

 

 

 

 

 

(131.9

)

 

 

(6.2

)

 

 

Capital expenditures

 

 

 

 

 

 

(21.9

)

 

 

(20.5

)

 

 

 Proceeds from sale of assets

 

 

 

 

 

 

0.1

 

 

 

 

 

 

Net cash used in investing activities from continuing operations

 

 

 

 

 

 

(153.7

)

 

 

(26.7

)

 

 

Financing activities:

 

 

 

 

 

 

 

 

 

 

Proceeds from the issuance of long-term debt

 

 

 

 

 

 

200.0

 

 

 

 

 

 

Repayment of debt

 

 

 

 

 

 

(309.8

)

 

 

 

 

 

Debt issuance costs

 

 

 

 

 

 

(3.2

)

 

 

 

 

 

Credit agreement borrowings

 

 

 

 

 

 

100.0

 

 

 

 

 

 

Payment under finance leases

 

 

 

 

 

 

(0.6

)

 

 

(0.4

)

 

 

Payments of employee taxes withheld from share-based awards

 

 

 

 

 

 

(11.5

)

 

 

(8.5

)

 

 

Proceeds from shares issued under equity plans

 

 

 

 

 

 

2.9

 

 

 

2.5

 

 

 

Net cash used in financing activities from continuing operations

 

 

 

 

 

 

(22.2

)

 

 

(6.4

)

 

 

Net cash flows from continuing operations

 

 

 

 

 

 

(205.4

)

 

 

(11.1

)

 

 

   Net operating cash flows of discontinued operations

 

 

 

 

 

 

(0.4

)

 

 

(0.8

)

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

 

 

 

 

(1.2

)

 

 

(0.3

)

 

 

Net decrease in cash, cash equivalents and restricted cash

 

 

 

 

 

 

(207.0

)

 

 

(12.2

)

 

 

Cash, cash equivalents and restricted cash at beginning of period

 

 

 

 

 

 

349.4

 

 

 

381.5

 

 

 

Cash, cash equivalents and restricted cash at end of period

 

 

 

 

 

$

142.4

 

 

$

369.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Non-GAAP Measures

 

 

Computation of Adjusted Earnings
Per Share

 

 

(in millions, except per share
data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted income from continuing operations and adjusted income from continuing operations per diluted common share (Adjusted EPS) are non-GAAP

 

 

 

 

measures for reporting financial performance and exclude the impact of certain items and, therefore, have not been calculated in accordance with GAAP. Management

 

 

believes that exclusion of these items assists in providing a more complete understanding of the Company’s underlying continuing operations results and trends and allows

 

for comparability with our peer company index and industry. The Company uses these measures along with the corresponding GAAP financial measures

 

 

 

to manage the Company’s business and to evaluate its performance compared to prior periods and the marketplace. The Company defines adjusted

 

 

 

 

income from continuing operations before amortization of intangible assets, depreciation, stock-based compensation, foreign transaction gain/loss, and

 

 

 

acquisition and restructuring related items and other. The estimated impact to income taxes includes the impact to the effective tax rate, current tax provision and

 

 

deferred tax provision, and excludes the impact of discrete items, including transaction related expenses and release of valuation allowance, or benefit related to the add-backs.*

 

Adjusted EPS reflects adjusted income on a per share basis using weighted average diluted shares outstanding.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the most directly comparable GAAP financial measures to the non-GAAP financial measures.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Net income (loss) attributable to Kratos

 

$

(4.7

)

 

$

1.1

 

 

$

(20.6

)

 

$

3.0

 

 

 

Less: GAAP provision (benefit) for income taxes

 

 

0.5

 

 

 

(3.6

)

 

 

(3.8

)

 

 

(6.3

)

 

 

Less: Net (income) loss attributable to noncontrolling interest

 

 

0.3

 

 

 

(0.2

)

 

 

0.3

 

 

 

(0.2

)

 

 

Less: Income (loss) from discontinued operations, net of income taxes

 

 

(0.9

)

 

 

0.3

 

 

 

(0.7

)

 

 

0.3

 

 

 

Loss from continuing operations before taxes

 

 

(4.8

)

 

 

(2.4

)

$

 

(24.8

)

 

 

(3.2

)

 

 

Add: Amortization of intangible assets

 

 

1.6

 

 

 

1.2

 

 

 

3.3

 

 

 

2.6

 

 

 

Add: Amortization of capitalized contract and development costs

 

 

0.3

 

 

 

0.3

 

 

 

0.6

 

 

 

0.5

 

 

 

Add: Depreciation

 

 

5.3

 

 

 

5.8

 

 

 

10.6

 

 

 

10.7

 

 

 

Add: Stock-based compensation

 

 

6.3

 

 

 

6.6

 

 

 

13.3

 

 

 

12.8

 

 

 

Add: Loss on extinguishment of debt

 

 

 

 

 

 

 

 

13.0

 

 

 

 

 

 

Add: Foreign transaction loss

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

 

 

0.2

 

 

 

Add: Acquisition and restructuring related items and other

 

 

6.0

 

 

 

0.3

 

 

 

6.6

 

 

 

0.5

 

 

 

   Non-GAAP Adjusted income from continuing
operations before income taxes

 

 

14.8

 

 

 

11.9

 

 

 

22.7

 

 

 

24.1

 

 

 

Income taxes on Non-GAAP measure Adjusted income from continuing operations*

 

 

5.4

 

 

 

4.3

 

 

 

8.2

 

 

 

8.8

 

 

 

   Non-GAAP Adjusted net income

 

$

9.4

 

 

$

7.6

 

 

$

14.5

 

 

$

15.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

 

$

(0.04

)

 

$

0.01

 

 

$

(0.16

)

 

$

0.02

 

 

 

Less: GAAP provision (benefit) for income taxes

 

 

 

 

 

(0.03

)

 

 

(0.03

)

 

 

(0.05

)

 

 

Less: Net income (loss) attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less: Loss (income) from discontinued operations, net of income taxes

 

 

 

 

 

 

 

 

(0.01

)

 

 

 

 

 

Add: Amortization of intangible assets

 

 

0.01

 

 

 

0.01

 

 

 

0.03

 

 

 

0.02

 

 

 

Add: Amortization of capitalized contract and development costs

 

 

 

 

 

 

 

 

 

 

 

0.01

 

 

 

Add: Depreciation

 

 

0.04

 

 

 

0.05

 

 

 

0.08

 

 

 

0.08

 

 

 

Add: Stock-based compensation

 

 

0.05

 

 

 

0.05

 

 

 

0.11

 

 

 

0.10

 

 

 

Add: Loss on extinguishment of debt

 

 

 

 

 

 

 

 

0.10

 

 

 

 

 

 

Add: Foreign transaction loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Add: Acquisition and restructuring related items and other

 

 

0.05

 

 

 

 

 

 

0.05

 

 

 

0.01

 

 

 

Income taxes on Non-GAAP measure Adjusted income from continuing operations*

 

 

(0.04

)

 

 

(0.03

)

 

 

(0.06

)

 

 

(0.07

)

 

 

Adjusted income from continuing operations per diluted
common share

 

$

0.07

 

 

$

0.06

 

 

$

0.11

 

 

$

0.12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average diluted common shares outstanding

 

 

126.4

 

 

 

127.7

 

 

 

126.2

 

 

 

127.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*The impact to income taxes is calculated by recasting income before income taxes to include the add-backs involved in determining Adjusted income from continuing

 

operations before income taxes and recalculating the income tax provision (benefit), including current and deferred income taxes, using the Adjusted income from continuing

operations before income taxes. The recalculation also adjusts for any discrete tax expense, including transaction related expenses and the release of valuation allowance, or

benefit related to the add-backs.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Primary Logo

Source: Kratos Defense & Security Solutions, Inc.

 



Release – Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022



Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022

News and Market Data on Onconova Therapeutics

Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, August 11, 2022

NEWTOWN, Pa., Aug. 04, 2022 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company intends to release its second quarter 2022 financial results on Thursday, August 11, 2022. Management plans to host a conference call and live webcast at 4:30 p.m. ET on the same day to discuss these results and provide an update on its pipeline programs.

Conference Call and Webcast Information

Interested parties who wish to participate in the conference call may do so by dialing (800) 289-0571 for domestic and (856) 344-9290 for international callers and using conference ID 3600715.

Those interested in listening to the conference call via the internet may do so by visiting the investors and media page on the Company’s website at www.onconova.com and clicking on the webcast link. In addition to the live webcast, a replay will be available on the Onconova website for 90 days following the call.

About Onconova Therapeutics, Inc.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Onconova’s novel, proprietary multi-kinase inhibitor narazaciclib (formerly ON 123300) is being evaluated in two separate and complementary Phase 1 dose-escalation and expansion studies. These trials are currently underway in the United States and China.

Onconova’s product candidate rigosertib is being studied in an investigator-sponsored study program, including in a dose-escalation and expansion Phase 1/2a investigator-sponsored study with oral rigosertib in combination with nivolumab for patients with KRAS+ non-small cell lung cancer.

For more information, please visit 
www.onconova.com.

Company Contact:
Mark Guerin
Onconova Therapeutics, Inc.
267-759-3680

ir@onconova.us
https://www.onconova.com/contact/

Investor Contact:
Bruce Mackle
LifeSci Advisors, LLC
646-889-1200

bmackle@lifesciadvisors.com

 


Release – Alvopetro Announces Inaugural Sustainability Report, July 2022 Sales Volumes, & Operational Update



Alvopetro Announces Inaugural Sustainability Report, July 2022 Sales Volumes, & Operational Update

Research, News, and Market Data on Alvopetro Energy

Aug 04, 2022

CALGARY, AB, Aug. 4, 2022 /CNW/ – Alvopetro Energy Ltd. (TSXV: ALV) (OTCQX: ALVOF) announces our inaugural sustainability report for the year-ended December 31, 2021, July sales volumes and an operational update.

Inaugural Sustainability Report

We are pleased to present our inaugural 2021 Sustainability Report (the “Report”), highlighting the operational milestones achieved through the development of our Caburé project and outlining Alvopetro’s approach to environmental, social and governance (“ESG”) practices. The Report was approved by the Company’s Board of Directors and provides stakeholders insight into our environmental stewardship, community involvement and corporate governance practices. A full copy of the Report can be found on our website at https://alvopetro.com/Sustainability.

Corey Ruttan, President and Chief Executive Officer, commented: “Our goal while developing this sustainability report was to create transparency on how we manage our business objectives focused on innovation, business strength and our approach to sustainability by; responsibly supplying energy, strengthening communities and our workforce, and minimizing our impact.”

2021 ESG highlights included:

  • Alvopetro’s locally produced natural gas resulted in average savings of 48% for consumers relative to imported LNG and 53% lower GHG emissions relative to fuel oil;
  • 100% of produced water reinjected;
  • Scope 1 & 2 emissions intensity of 4.7 kg CO2e per boe;
  • 65% less vegetation removed than allowed in our permit during the construction of our Murucututu pipeline extension;
  • 75 jobs created during Murucututu pipeline construction;
  • Zero lost-time safety incidents; and
  • Budgeting $0.20/boe to voluntary social programs.

July Sales Volumes and Facility Expansion

Our July sales volumes averaged 2,514 boepd based on field estimates, including natural gas sales of 14.4 MMcfpd, associated natural gas liquids sales from condensate of 108 bopd and oil sales of 6 bopd, a 7% increase from our Q2 average of 2,359 boepd. Our Caburé gas processing facility expansion was commissioned and completed in late July. We now have available processing capacity of up to 500,000 cubic metres per day (18 MMcfpd).  Prior to the expansion our sales volumes were limited by the gas processing facility capacity. With the expanded capacity, our production is expected to be driven by Alvopetro’s share of available Caburé unit production and production additions from new projects. 

Operational Update

In April, we completed drilling our 182-C1 well on Block 182 and, based on open-hole wireline logs, the well discovered 25 metres of potential net natural gas pay in the Agua Grande formation with an average 34% water saturation and average porosity of 8.2%, using a 6% porosity cut-off, 50% Vshale cut-off and 50% water saturation cut-off.  We have commenced completion and testing operations using the drilling rig.  After perforating and cleaning up the well we will complete a 72-hour formation test.  We then plan to move the drilling rig on the same drilling location to drill a follow up well further east from the bounding fault to further assess the Agua Grande potential and to target the Sergi Formation.

In July, we completed drilling our second 2022 exploration well (183-B1) on the fault block immediately east to our 182-C1 discovery.  The 183-B1 location was also a multi-zone pre-rift prospect targeting both the Agua Grande and Sergi Formations.  Based on open-hole logs and collected fluid samples, the 183-B1 well encountered multiple zones of interest with an aggregate 34.3 metres of potential net hydrocarbon pay, using a 6% porosity cut-off, 50% Vshale cut-off and 50% water saturation cut-off.  Subject to equipment availability we expect to commence multi-zone formation tests later in the third quarter. 

On our Murucututu project, we commenced commissioning of our field production facility at our 183-1 location in July and subject to final ANP inspection we expect to have our 183-1 well on production near the end of the month. We also commenced field installation of the pipeline extension to tie-in our 197-1 well in June and expect construction to be completed later in the third quarter. Subject to receipt of regulatory approvals, we plan to complete and tie-in the 197-1 well in the fourth quarter.

At the Caburé Unit, the unit operator has commenced drilling the Unit C well (49.1% Alvopetro) targeting development and exploration potential in the Pojuca, Marfim and Caruaçu formations. Drilling is expected to be completed near the end of August.

Semi-Annual Natural Gas Price Redetermination

Pursuant to the terms of our long-term gas sales agreement with Bahiagás, our natural gas price effective August 1, 2022 is BRL1.94/m3 or $11.28/Mcf (based on our average heat content to date of 107% and the July 31, 2022 BRL/USD foreign exchange rate of 5.19).  The adjusted price is based on the ceiling price in the contract, which was adjusted to $10.22/MMBtu effective August 1, 2022. While the ceiling price increased by 6% from the February 1, 2022 ceiling price, due to the appreciation of the BRL relative to the USD in the first half of 2022 compared to the latter half of 2021, the BRL denominated contractual price remained consistent.  This price will be effective for all natural gas sales from August 1, 2022 to January 31, 2023.

Corporate Presentation

Alvopetro’s updated corporate presentation is available on our website at:http://www.alvopetro.com/corporate-presentation

Social Media

Follow Alvopetro on our social media channels at the following links:Twitter – https://twitter.com/AlvopetroEnergyInstagram – 
https://www.instagram.com/alvopetro/LinkedIn – 
https://www.linkedin.com/company/alvopetro-energy-ltdYouTube: https://www.youtube.com/channel/UCgDn_igrQgdlj-maR6fWB0w

Alvopetro Energy Ltd.’s vision is to become a
leading independent upstream and midstream operator in 
Brazil. Our
strategy is to unlock the on-shore natural gas potential in the state of Bahia
in 
Brazil,
building off the development of our Caburé natural gas field and our strategic
midstream infrastructure.

Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this news release.

All amounts contained in this new release are in United States dollars,
unless otherwise stated and all tabular amounts are in thousands of 
United States dollars,
except as otherwise noted.

Abbreviations:

boepd                    
=             
barrels of oil equivalent (“boe”) per
daybopd                      
=             
barrels of oil and/or natural gas liquids (condensate) per
dayMMcf                     
=             
million cubic feetMMcfpd               
 
=             
million cubic feet per day

BOE Disclosure. The term barrels of oil
equivalent (“boe”) may be misleading, particularly if used in
isolation. A boe conversion ratio of six thousand cubic feet per barrel
(6Mcf/bbl) of natural gas to barrels of oil equivalence is based on an energy equivalency
conversion method primarily applicable at the burner tip and does not represent
a value equivalency at the wellhead. All boe conversions in this news release
are derived from converting gas to oil in the ratio mix of six thousand cubic
feet of gas to one barrel of oil.

Testing and Well Results.  Data obtained
from the 183-B1 and 182-C1 wells identified in this press release, including
hydrocarbon shows, open-hole logging, net pay and porosities, should be
considered to be preliminary until testing, detailed analysis and
interpretation has been completed. Hydrocarbon shows can be seen during the
drilling of a well in numerous circumstances and do not necessarily indicate a
commercial discovery or the presence of commercial hydrocarbons in a well.
There is no representation by Alvopetro that the data relating to the 183-B1
well nor the 182-C1 well contained in this press release is necessarily
indicative of long-term performance or ultimate recovery. The reader is
cautioned not to unduly rely on such data as such data may not be indicative of
future performance of the well or of expected production or operational results
for Alvopetro in the future.

Forward-Looking Statements and Cautionary Language. This
news release contains “forward-looking information” within the
meaning of applicable securities laws. The use of any of the words
“will”, “expect”, “intend” and other similar
words or expressions are intended to identify forward-looking information.
Forward
?looking
statements involve significant risks and uncertainties, should not be read as
guarantees of future performance or results, and will not necessarily be
accurate indications of whether or not such results will be achieved. A number
of factors could cause actual results to vary significantly from the expectations
discussed in the forward-looking statements. These forward-looking statements
reflect current assumptions and expectations regarding future events.
Accordingly, when relying on forward-looking statements to make decisions,
Alvopetro cautions readers not to place undue reliance on these statements, as
forward-looking statements involve significant risks and uncertainties. More
particularly and without limitation, this news release contains forward-looking
information concerning potential hydrocarbon pay in the 183-B1 and the 182-C1
wells, exploration and development prospects of Alvopetro and the expected
timing of certain of Alvopetro’s testing and operational activities. The
forward
?looking
statements are based on certain key expectations and assumptions made by
Alvopetro, including but not limited to expectations and assumptions concerning
testing results of the 183-B1 well and the 182-C1 well, equipment availability,
the timing of regulatory licenses and approvals, the success of future
drilling, completion, testing, recompletion and development activities, the
outlook for commodity markets and ability to access capital markets, the impact
of the COVID-19 pandemic, the performance of producing wells and reservoirs,
well development and operating performance, foreign exchange rates, general
economic and business conditions, weather and access to drilling locations, the
availability and cost of labour and services, environmental regulation,
including regulation relating to hydraulic fracturing and stimulation, the
ability to monetize hydrocarbons discovered, the regulatory and legal
environment and other risks associated with oil and gas operations. The reader
is cautioned that assumptions used in the preparation of such information,
although considered reasonable at the time of preparation, may prove to be
incorrect. Actual results achieved during the forecast period will vary from
the information provided herein as a result of numerous known and unknown risks
and uncertainties and other factors.  Although Alvopetro believes that the
expectations and assumptions on which such forward-looking information is based
are reasonable, undue reliance should not be placed on the forward-looking
information because Alvopetro can give no assurance that it will prove to be
correct. Readers are cautioned that the foregoing list of factors is not
exhaustive. Additional information on factors that could affect the operations
or financial results of Alvopetro are included in our annual information form
which may be accessed on Alvopetro’s SEDAR profile at 
www.sedar.com.
The forward-looking information contained in this news release is made as of
the date hereof and Alvopetro undertakes no obligation to update publicly or
revise any forward-looking information, whether as a result of new information,
future events or otherwise, unless so required by applicable securities laws.

SOURCE Alvopetro Energy Ltd.

 


Release – Salem Media Group, Inc. Announces Second Quarter 2022 Total Revenue of $68.7 Million



Salem Media Group, Inc. Announces Second Quarter 2022 Total Revenue of $68.7 Million

Research, News, and Market Data on Salem Media

August 04, 2022 4:05pm EDT

Earnings
Webcast

IRVING, Texas–(BUSINESS WIRE)– Salem Media Group, Inc. (Nasdaq: SALM) released its results for the three and six months ended June 30, 2022.

Second Quarter
2022 Results

For the quarter ended June 30, 2022 compared to the quarter ended June 30, 2021:

Consolidated

  • Total revenue increased 7.7% to $68.7 million from $63.8 million;
  • Total operating expenses increased 5.5% to $61.4 million from $58.1 million;
  • Operating expenses, excluding gains or losses on the disposition of assets, stock-based compensation expense, debt modification costs, impairments, depreciation expense and amortization expense (1) increased 10.7% to $60.9 million from $55.0 million;
  • The company’s operating income increased 29.9% to $7.3 million from $5.6 million;
  • The company recognized $3.9 million in film distribution income from an unconsolidated equity investment;
  • The company’s net income increased 303.9% to $9.1 million, or $0.33 net income per diluted share from $2.3 million, or $0.08 net income per diluted share;
  • EBITDA (1) increased 60.9% to $14.5 million from $9.0 million; and
  • Adjusted EBITDA (1) increased 33.6% to $11.7 million from $8.7 million.

Broadcast

  • Net broadcast revenue increased 12.1% to $52.5 million from $46.8 million;
  • Station Operating Income (“SOI”) (1) decreased 6.2% to $10.0 million from $10.6 million;
  • Same Station (1) net broadcast revenue increased 12.2% to $52.4 million from $46.7 million; and
  • Same Station SOI (1) decreased 5.9% to $10.0 million from $10.6 million.

Digital Media

  • Digital media revenue increased 4.5% to $10.8 million from $10.3 million; and
  • Digital Media Operating Income (1) increased 26.5% to $2.5 million from $2.0 million.

Publishing

  • Publishing revenue decreased 18.5% to $5.4 million from $6.7 million; and
  • Publishing Operating Loss (1) was $6,000 as compared to publishing operating income of $0.2 million.

Included in the results for the quarter ended June 30, 2022 are:

  • A $6.9 million ($5.1 million, net of tax, or $0.19 per diluted share) net gain on the disposition of assets reflects a $6.5 million pre-tax gain on the sale of land used in the company’s Denver, Colorado broadcast operations and a $0.5 million pre-tax gain on the sale of the company’s radio stations in Louisville, Kentucky that was offset with losses from various fixed asset disposals;
  • A $3.9 million ($2.9 million, net of tax, or $0.11 per share) impairment charge to the value of broadcast licenses in Columbus, Dallas, Greenville, Honolulu, Orlando, Portland, and Sacramento;
  • A $0.1 million ($0.1 million, net of tax) goodwill impairment charge; and
  • A $0.1 million non-cash compensation charge ($0.1 million, net of tax) related to the expensing of stock options.

Included in the results for the quarter ended June 30, 2021 are:

  • A $0.3 million ($0.2 million, net of tax, or $0.01 per diluted share) net gain on the disposition of assets relates to $0.5 million pre-tax gain on the sale of Singing News Magazine and Singing News Radio offset by an additional $0.1 million pre-tax loss recorded at closing on the sale of radio station WKAT-AM and FM translator in Miami, Florida; and
  • A $0.1 million non-cash compensation charge ($0.1 million, net of tax) related to the expensing of stock options.

Per share numbers are calculated based on 27,570,881 diluted weighted average shares for the quarter ended June 30, 2022, and 27,232,423 diluted weighted average shares for the quarter ended June 30, 2021.

Year to Date 2022
Results

For the six months ended June 30, 2022 compared to the six months ended June 30, 2021:

Consolidated

  • Total revenue increased 6.6% to $131.3 million from $123.1 million;
  • Total operating expenses increased 5.2% to $119.0 million from $113.1 million;
  • Operating expenses, excluding gains or losses on the disposition of assets, stock-based compensation expense, debt modification costs, changes in the estimated fair value of contingent earn-out considerationimpairments, depreciation expense and amortization expense (1) increased 9.6% to $116.7 million from $106.5 million;
  • The company’s operating income increased 23.1% to $12.3 million from $10.0 million;
  • The company recognized $3.9 million in film distribution income from an unconsolidated equity investment;
  • The company’s net income increased 320.8% to $10.9 million, or $0.39 net income per diluted share from $2.6 million, or $0.10 net income per diluted share;
  • EBITDA (1) increased 37.0% to $22.7 million from $16.5 million; and
  • Adjusted EBITDA (1) increased 11.2% to $18.5 million from $16.7 million.

Broadcast

  • Net broadcast revenue increased 11.1% to $100.9 million from $90.8 million;
  • SOI (1) decreased 4.9% to $20.3 million from $21.3 million;
  • Same station (1) net broadcast revenue increased 10.8% to $100.5 million from $90.7 million; and
  • Same station SOI (1) decreased 5.4% to $20.3 million from $21.5 million.

Digital media

  • Digital media revenue increased 5.7% to $21.1 million from $20.0 million; and
  • Digital media operating income (1) increased 47.9% to $4.4 million from $2.9 million.

Publishing

  • Publishing revenue decreased 24.6% to $9.3 million from $12.3 million; and
  • Publishing Operating Loss (1) was $0.6 million compared to publishing operating income of $0.7 million.

Included in the results for the six months ended June 30, 2022 are:

  • A $8.6 million ($6.4 million, net of tax, or $0.23 per diluted share) net gain on the disposition of assets relates primarily to the $6.5 million pre-tax gain on the sale of land used in the company’s Denver, Colorado broadcast operations, the $1.8 million pre-tax gain on sale of land used in the company’s Phoenix, Arizona broadcast operations, and $0.5 million pre-tax gain on the sale of the company’s radio stations in Louisville, Kentucky offset by various fixed asset disposals;
  • A $3.9 million ($2.9 million, net of tax, or $0.11 per share) impairment charge to the value of broadcast licenses in Columbus, Dallas, Greenville, Honolulu, Orlando, Portland, and Sacramento;
  • A $0.1 million ($0.1 million, net of tax) goodwill impairment charge;
  • A $0.2 million ($0.2 million, net of tax, or $0.01 per share) charge for debt modification costs; and
  • A $0.2 million non-cash compensation charge ($0.1 million, net of tax) related to the expensing of stock options.

Included in the results for the six months ended June 30, 2021 are:

  • A $0.1 million net gain on the disposition of assets relating to a $0.5 million pre-tax gain on the sale of Singing News Magazine and Singing News Radio offset by $0.4 million additional loss recorded at closing on the sale of radio station WKAT-AM and FM translator in Miami, Florida and various fixed asset disposals; and
  • A $0.2 million non-cash compensation charge ($0.1 million, net of tax) related to the expensing of stock options.

Per share numbers are calculated based on 27,590,644 diluted weighted average shares for the six months ended June 30, 2022, and 27,185,598 diluted weighted average shares for the six months ended June 30, 2021.

Balance Sheet

As of June 30, 2022, the company had $114.7 million outstanding on the 7.125% senior secured notes due 2028 (“2028 Notes”), $44.7 million outstanding on 6.75% senior secured notes due 2024 (“2024 Notes”), and $10,000 outstanding balance on the ABL Facility.

Acquisitions and
Divestitures

The following transactions were completed since April 1, 2022:

  • On June 27, 2022, the company sold 9.3 acres of land in the Denver area for $8.2 million. The land was being used as the transmitter site for radio stations KRKS-AM and KBJD-AM and was an integral part of its broadcast operations for these stations. The company will continue broadcasting both KRKS-AM and KBJD-AM from this site.
  • On May 25, 2022, the company sold radio stations WFIA-AM, WFIA-FM and WGTK-AM in Louisville, Kentucky for $4.0 million.
  • On May 2, 2022, the company acquired websites and related assets of Retirement Media for $0.2 million in cash.

Pending
transactions

  • On June 2, 2021, the company entered into an Asset Purchase Agreement to acquire radio station KKOL-AM in Seattle, Washington for $0.5 million. The company paid $0.1 million of cash into an escrow account and began operating the station under a Local Marketing Agreement on June 7, 2021.

Conference Call
Information

Salem will host a teleconference to discuss its results on August 4, 2022 at 4:00 p.m. Central Time. To access the teleconference, please dial (888) 770-7291, and then ask to be joined into the Salem Media Group Second Quarter 2022 call or listen via the investor relations portion of the company’s website, located at investor.salemmedia.com. A replay of the teleconference will be available through August 18, 2022 and can be heard by dialing (800) 770-2030, passcode 2413416 or on the investor relations portion of the company’s website, located at investor.salemmedia.com.

Follow us on Twitter @SalemMediaGrp.

Third Quarter
2022 Outlook

For the third quarter of 2022, the company is projecting total revenue to increase between 6% and 8% from third quarter 2021 total revenue of $66.0 million. The company is also projecting operating expenses before gains or losses on the sale or disposal of assets, stock-based compensation expense, changes in the estimated fair value of contingent earn-out consideration, impairments, depreciation expense and amortization expense to increase between 11% and 14% compared to the third quarter of 2021 non-GAAP operating expenses of $55.2 million.

A
reconciliation of non-GAAP operating expenses, excluding gains or losses
on the disposition of assets, stock-based compensation expense, changes in the
estimated fair value of contingent earn-out consideration, impairments,
depreciation expense and amortization expense to the most directly
comparable GAAP measure is not available without unreasonable efforts on a
forward-looking basis due to the potential high variability, complexity and low
visibility with respect to the charges excluded from this non-GAAP financial
measure, in particular, the change in the estimated fair value of earn-out
consideration, impairments and gains or losses from the disposition of fixed
assets. The company expects the variability of the above charges may have a
significant, and potentially unpredictable, impact on its future GAAP financial
results.

About Salem Media
Group, Inc.

Salem Media Group is America’s leading multimedia company specializing in Christian and conservative content, with media properties comprising radio, digital media and book and newsletter publishing. Each day Salem serves a loyal and dedicated audience of listeners and readers numbering in the millions nationally. With its unique programming focus, Salem provides compelling content, fresh commentary and relevant information from some of the most respected figures across the Christian and conservative media landscape. Learn more about Salem Media Group, Inc. at www.salemmedia.comFacebook and Twitter.

Forward-Looking
Statements

Statements used in this press release that relate to future plans, events, financial results, prospects or performance are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those anticipated as a result of certain risks and uncertainties, including but not limited to the ability of Salem to close and integrate announced transactions, market acceptance of Salem’s radio station formats, competition from new technologies, adverse economic conditions, and other risks and uncertainties detailed from time to time in Salem’s reports on Forms 10-K, 10-Q, 8-K and other filings filed with or furnished to the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Salem undertakes no obligation to update or revise any forward-looking statements to reflect new information, changed circumstances or unanticipated events.

(1) Regulation G

Management
uses certain non-GAAP financial measures defined below in communications
with investors, analysts, rating agencies, banks and others to assist such
parties in understanding the impact of various items on its financial
statements. The company uses these non-GAAP financial measures to evaluate
financial results, develop budgets, manage expenditures and as a measure of
performance under compensation programs.

The
company’s presentation of these non-GAAP financial measures should not be considered
as a substitute for or superior to the most directly comparable financial
measures as reported in accordance with GAAP.

Regulation
G defines and prescribes the conditions under which certain non-GAAP financial
information may be presented in this earnings release. The company closely
monitors EBITDA, Adjusted EBITDA, Station Operating Income (“SOI”), Same
Station net broadcast revenue, Same Station broadcast operating expenses, Same
Station Operating Income, Digital Media Operating Income, Publishing Operating
Income (Loss), and operating expenses excluding gains or losses on the
disposition of assets, stock-based compensation, changes in the estimated fair
value of contingent earn-out consideration, impairments, depreciation and
amortization, all of which are non-GAAP financial measures. The company
believes that these non-GAAP financial measures provide useful information
about its core operating results, and thus, are appropriate to enhance the
overall understanding of its financial performance. These non-GAAP financial
measures are intended to provide management and investors a more complete
understanding of its underlying operational results, trends and performance.

The
company defines Station Operating Income (“SOI”) as net broadcast revenue minus
broadcast operating expenses. The company defines Digital Media Operating
Income as net Digital Media Revenue minus Digital Media Operating Expenses. The
company defines Publishing Operating Income (Loss) as net Publishing Revenue
minus Publishing Operating Expenses. The company defines EBITDA as net income
before interest, taxes, depreciation, and amortization. The company defines
Adjusted EBITDA as EBITDA before gains or losses on the disposition of assets,
before debt modification costs, before changes in the estimated fair value of
contingent earn-out consideration, before impairments, before net miscellaneous
income and expenses, before (gain) loss on early retirement of long-term debt
and before non-cash compensation expense. SOI, Digital Media Operating Income,
Publishing Operating Income (Loss), EBITDA and Adjusted EBITDA are commonly
used by the broadcast and media industry as important measures of performance
and are used by investors and analysts who report on the industry to provide
meaningful comparisons between broadcasters. SOI, Digital Media Operating
Income, Publishing Operating Income (Loss), EBITDA and Adjusted EBITDA are not
measures of liquidity or of performance in accordance with GAAP and should be
viewed as a supplement to and not a substitute for or superior to its results
of operations and financial condition presented in accordance with GAAP. The
company’s definitions of SOI, Digital Media Operating Income, Publishing
Operating Income (Loss), EBITDA and Adjusted EBITDA are not necessarily
comparable to similarly titled measures reported by other companies.

The
company defines Same Station net broadcast revenue as broadcast revenue from
its radio stations and networks that the company owns or operates in the same
format on the first and last day of each quarter, as well as the corresponding
quarter of the prior year. The company defines Same Station broadcast operating
expenses as broadcast operating expenses from its radio stations and networks
that the company owns or operates in the same format on the first and last day
of each quarter, as well as the corresponding quarter of the prior year. The
company defines Same Station SOI as Same Station net broadcast revenue less
Same Station broadcast operating expenses. Same Station operating results
include those stations that the company owns or operates in the same format on
the first and last day of each quarter, as well as the corresponding quarter of
the prior year. Same Station operating results for a full calendar year are
calculated as the sum of the Same Station-results for each of the four quarters
of that year. The company uses Same Station operating results, a non-GAAP
financial measure, both in presenting its results to stockholders and the
investment community, and in its internal evaluations and management of the
business. The company believes that Same Station operating results provide a
meaningful comparison of period over period performance of its core broadcast
operations as this measure excludes the impact of new stations, the impact of
stations the company no longer owns or operates, and the impact of stations
operating under a new programming format. The company’s presentation of Same
Station operating results are not intended to be considered in isolation or as
a substitute for the financial information prepared and presented in accordance
with GAAP. The company’s definition of Same Station operating results is not
necessarily comparable to similarly titled measures reported by other
companies.

For
all non-GAAP financial measures, investors should consider the limitations
associated with these metrics, including the potential lack of comparability of
these measures from one company to another.

The
Supplemental Information tables that follow the condensed consolidated financial
statements provide reconciliations of the non-GAAP financial measures that the
company uses in this earnings release to the most directly comparable measures
calculated in accordance with GAAP. The company uses non-GAAP financial
measures to evaluate financial performance, develop budgets, manage
expenditures, and determine employee compensation. The company’s presentation
of this additional information is not to be considered as a substitute for or
superior to the directly comparable measures as reported in accordance with
GAAP.

 

Salem Media Group, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

 

Three Months Ended

 

Six Months Ended

June 30,

 

June 30,

2021

 

2022

 

2021

 

2022

(Unaudited)

Net broadcast revenue

$

46,783

$

52,452

$

90,831

$

100,884

Net digital media revenue

10,339

10,804

19,958

21,104

Net publishing revenue

6,660

5,426

12,346

9,303

Total revenue

63,782

68,682

123,135

131,291

Operating expenses:

 

 

 

 

Broadcast operating expenses

36,162

42,489

69,505

80,610

Digital media operating expenses

8,338

8,273

17,011

16,746

Publishing operating expenses

6,426

5,432

11,631

9,899

Unallocated corporate expenses

4,192

4,781

8,480

9,591

 

Debt modification costs

 

 

 

 

20

 

 

 

 

248

 

Depreciation and amortization

 

 

3,286

 

 

3,190

 

 

6,456

 

 

6,466

 

Change in the estimated fair value of contingent earn-out consideration

 

 

 

 

 

 

 

 

(5)

 

Impairment of indefinite-lived long-term assets other than goodwill

 

 

 

 

3,935

 

 

 

 

3,935

 

Impairment of goodwill

 

 

 

 

127

 

 

 

 

127

Net (gain) loss on the disposition of assets

(263)

(6,893)

55

(8,628)

Total operating expenses

58,141

61,354

113,138

118,989

Operating income

5,641

7,328

9,997

12,302

Other income (expense):

 

 

 

 

Interest income

149

1

149

Interest expense

(3,935)

(3,389)

(7,861)

(6,783)

Gain (loss) on early retirement of long-term debt

35

(18)

 

Earnings from equity method investment

 

 

 

 

3,913

 

 

 

 

3,913

Net miscellaneous income and (expenses)

63

(1)

85

Net income before income taxes

1,769

8,035

2,222

9,563

Benefit from income taxes

(488)

(1,082)

(358)

(1,293)

Net income

$

2,257

$

9,117

$

2,580

$

10,856

 

 

 

 

Basic income per share Class A and Class B common stock

$

0.08

$

0.33

$

0.10

$

0.39

Diluted income per share Class A and Class B common stock

$

0.08

$

0.33

$

0.10

$

0.39

 

 

 

 

Basic weighted average Class A and Class B common stock shares outstanding

26,869,145

27,214,787

26,802,892

27,196,081

Diluted weighted average Class A and Class B common stock shares outstanding

27,232,423

27,570,881

27,185,598

27,590,644

 

 

Salem Media Group, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

June 30, 2022

 

 

 

 

 

 

(Unaudited)

Assets

 

 

 

 

 

 

Cash

 

$

1,785

 

$

2,540

Trade accounts receivable, net

 

 

25.663

 

 

29,271

Other current assets

 

 

14,066

 

 

15,856

Property and equipment, net

 

 

79,339

 

 

79,713

Operating and financing lease right-of-use assets

 

 

43,665

 

 

44,110

Intangible assets, net

 

 

346,438

 

 

339,160

Deferred financing costs

 

 

843

 

 

774

Other assets

 

 

4,313

 

 

3,845

Total assets

 

$

516,112

 

$

515,269

 

 

 

 

 

 

 

Liabilities and
Stockholders’ Equity

 

 

 

 

 

 

Current liabilities

 

$

51,455

 

$

56,161

Long-term debt

 

 

170,581

 

 

155,595

Operating and financing lease liabilities, less current portion

 

 

42,273

 

 

42,652

Deferred income taxes

 

 

67,012

 

 

65,808

Other liabilities

 

 

6,580

 

 

5,718

Stockholders’ Equity

 

 

178,211

 

 

189,335

Total liabilities and stockholders’ equity

 

$

516,112

 

$

515,269

 

 

SALEM MEDIA GROUP, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’
EQUITY

(in thousands,
except share and per share data
)

 

 

 

 

Class A

 

Class B

 

 

 

 

 

 

 

 

 

 

Common Stock

 

Common Stock

 

Additional

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Paid-In

 

Accumulated

 

Treasury

 

 

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Deficit

 

Stock

 

Total

Stockholders’
equity, December 31, 2020

 

23,447,317

 

$

227

 

5,553,696

 

$

56

 

$

247,025

 

$

(78,023

)

 

$

(34,006

)

 

$

135,279

Stock-based compensation

 

 

 

 

 

 

 

 

78

 

 

 

 

 

 

 

 

78

Options
exercised

 

185,782

 

 

2

 

 

 

 

 

390

 

 

 

 

 

 

 

 

392

Net income

 

 

 

 

 

 

 

 

 

 

323

 

 

 

 

 

 

323

Stockholders’
equity,

March 31, 2021

 

23,633,099

 

$

229

 

5,553,696

 

$

56

 

$

247,493

 

$

(77,700

)

 

$

(34,006

)

 

$

136,072

Stock-based compensation

 

 

 

 

 

 

 

 

84

 

 

 

 

 

 

 

 

84

Net income

 

 

 

 

 

 

 

 

 

 

2,257

 

 

 

 

 

 

2,257

Stockholders’ equity, June 30, 2021

 

23,633,099

 

$

229

 

5,553,696

 

$

56

 

$

247,577

 

$

(75,443

)

 

$

(34,006

)

 

$

138,413

 

 

 

Class A

 

Class B

 

 

 

 

 

 

 

 

 

 

Common Stock

 

Common Stock

 

Additional

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Paid-In

 

Accumulated

 

Treasury

 

 

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Deficit

 

Stock

 

Total

Stockholders’
equity, December 31, 2021

 

23,922,974

 

$

232

 

5,553,696

 

$

56

 

$

248,438

 

$

(36,509

)

 

$

(34,006

)

 

$

178,211

Stock-based compensation

 

 

 

 

 

 

 

 

106

 

 

 

 

 

 

 

 

106

Options
exercised

 

40,913

 

 

 

 

 

 

 

94

 

 

 

 

 

 

 

 

94

Lapse of restricted shares

 

14,854

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

1,739

 

 

 

 

 

 

1,739

Stockholders’ equity,

March 31, 2022

 

23,978,741

 

$

232

 

5,553,696

 

$

56

 

$

248,638

 

$

(34,770

)

 

$

(34,006

)

 

$

180,150

Stock-based
compensation

 

 

 

 

 

 

 

 

68

 

 

 

 

 

 

 

 

68

Net income

 

 

 

 

 

 

 

 

 

 

9,117

 

 

 

 

 

 

9,117

Stockholders’
equity, June 30, 2022

 

23,978,741

 

$

232

 

5,553,696

 

$

56

 

$

248,706

 

$

(25,653

)

 

$

(34,006

)

 

$

189,335

 

 

Salem Media Group, Inc.

Supplemental Information

(in thousands)

 

Three Months Ended

 

Six Months Ended

June 30,

 

June 30,

2021

 

2022

 

2021

 

2022

(Unaudited)

Reconciliation of Total Operating Expenses to
Operating Expenses excluding Debt Modification Costs, Depreciation and
Amortization Expense, Changes in the Estimated Fair Value of Contingent
Earn-out Consideration, Impairments, Gains or Losses on the Disposition of
Assets and Stock-based Compensation Expense (Recurring Operating Expenses)

Operating Expenses

$

58,141

$

61,354

$

113,138

$

118,989

Less debt modification costs

 

 

 

 

 

(20)

 

 

 

 

 

(248)

Less depreciation and amortization expense

 

 

(3,286)

 

 

(3,190)

 

 

(6,456)

 

 

(6,466)

Less change in estimated fair value of contingent earn-out

consideration

5

Less impairment of indefinite-lived long-term assets other

than goodwill

 

 

 

 

(3,935)

 

 

 

 

(3,935)

Less impairment of goodwill

 

 

 

 

(127)

 

 

 

 

(127)

Less net gain (loss) on the disposition of assets

263

6,893

(55)

8,628

Less stock-based compensation expense

 

 

(84)

 

 

(68)

 

 

(162)

 

 

(174)

Total Recurring
Operating Expenses

$

55,034

$

60,907

$

106,465

$

116,672

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net Broadcast Revenue to Same
Station Net Broadcast Revenue

Net broadcast revenue

 

$

46,783

 

$

52,452

 

$

90,831

 

$

100,884

Net broadcast revenue – acquisitions

(14)

(247)

Net broadcast revenue – dispositions

 

 

(96)

 

 

(56)

 

 

(113)

 

 

(49)

Net broadcast revenue – format change

(65)

(111)

Same Station net broadcast revenue

 

$

46,687

 

$

52,382

 

$

90,653

 

$

100,477

 

 

 

 

Reconciliation
of Broadcast Operating Expenses to Same Station Broadcast Operating Expenses

Broadcast operating expenses

 

$

36,162

 

$

42,489

 

$

69,505

 

$

80,610

Broadcast operating expenses – acquisitions

(63)

(1)

(279)

Broadcast operating expenses – dispositions

 

 

(81)

 

 

(24)

 

 

(214)

 

 

(48)

Broadcast operating expenses – format change

(131)

(132)

Same Station broadcast operating expenses

 

$

36,081

 

$

42,402

 

$

69,159

 

$

80,151

 

 

 

 

Reconciliation of SOI to Same Station SOI

 

 

 

 

 

 

 

 

 

 

 

 

Station Operating Income

$

10,621

$

9,963

$

21,326

 

$

20,274

Station operating (income) loss – acquisitions

 

 

 

 

49

 

 

1

 

 

32

Station operating (income) loss – dispositions

(15)

(32)

101

(1)

Station operating (income) loss – format change

 

 

 

 

 

66

 

 

21

Same Station – Station Operating Income

$

10,606

$

9,980

$

21,494

$

20,326

 

 

Salem Media Group, Inc.

Supplemental Information

(in thousands)

 

Three Months Ended

 

Six Months Ended

June 30,

 

June 30,

2021

 

2022

 

2021

 

2022

(Unaudited)

Calculation of Station Operating Income, Digital
Media Operating Income and Publishing Operating Income (Loss)

Net broadcast revenue

$

46,783

$

52,452

$

90,831

$

100,884

Less broadcast operating expenses

 

 

(36,162)

 

 

(42,489)

 

 

(69,505)

 

 

(80,610)

Station Operating Income

$

10,621

$

9,963

$

21,326

$

20,274

 

 

 

 

 

 

 

 

 

 

 

 

 

Net digital media revenue

$

10,339

$

10,804

$

19,958

$

21,104

Less digital media operating expenses

 

 

(8,338)

 

 

(8,273)

 

 

(17,011)

 

 

(16,746)

Digital Media Operating Income

$

2,001

$

2,531

$

2,947

$

4,358

 

 

 

 

 

 

 

 

 

 

 

 

 

Net publishing revenue

$

6,660

$

5,426

$

12,346

$

9,303

Less publishing operating expenses

 

 

(6,426)

 

 

(5,432)

 

 

(11,631)

 

 

(9,899)

Publishing Operating Income (Loss)

$

234

$

(6)

$

715

$

(596)

The company defines EBITDA (1) as net income before interest, taxes, depreciation, and amortization. The table below presents a reconciliation of EBITDA (1) to Net Income (Loss), the most directly comparable GAAP measure. EBITDA (1) is a non-GAAP financial performance measure that is not to be considered a substitute for or superior to the directly comparable measures reported in accordance with GAAP. The company defines Adjusted EBITDA (1) as EBITDA (1) before gains or losses on the disposition of assets, before debt modification costs, before changes in the estimated fair value of contingent earn-out consideration, before impairments, before net miscellaneous income and expenses, before (gain) loss on early retirement of long-term debt and before non-cash compensation expense. The table below presents a reconciliation of Adjusted EBITDA (1) to Net Income (Loss), the most directly comparable GAAP measure. Adjusted EBITDA (1) is a non-GAAP financial performance measure that is not to be considered a substitute for or superior to the directly comparable measures reported in accordance with GAAP.

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

2021

 

2022

 

2021

 

2022

 

(Unaudited)

Net income

$

2,257

 

$

9,117

 

$

2,580

 

$

10,856

 

Plus interest expense, net of capitalized interest

 

3,935

 

 

3,389

 

 

7,861

 

 

6,783

 

Plus benefit from income taxes

 

(488

)

 

(1,082

)

 

(358

)

 

(1,293

)

Plus depreciation and amortization

 

3,286

 

 

3,190

 

 

6,456

 

 

6,466

 

Less interest income

 

 

 

(149

)

 

(1

)

 

(149

)

EBITDA

$

8,990

 

$

14,465

 

$

16,538

 

$

22,663

 

Plus net (gain) loss on the disposition of assets

 

(263

)

 

(6,893

)

 

55

 

 

(8,628

)

Plus change in the estimated fair value of contingent earn-out consideration

 

 

 

 

 

 

 

(5

)

Plus debt modification costs

 

 

 

20

 

 

 

248

 

Plus impairment of indefinite-lived long-term assets other than goodwill

 

 

 

3,935

 

 

 

 

3,935

 

Plus impairment of goodwill

 

 

 

127

 

 

 

 

127

 

Plus net miscellaneous (income) and expenses

 

(63

)

 

1

 

 

(85

)

 

 

Plus (gain) loss on early retirement of long- term debt

 

 

 

(35

)

 

 

 

18

 

Plus non-cash stock-based compensation

 

84

 

 

68

 

 

162

 

 

174

 

Adjusted EBITDA

$

8,748

 

$

11,688

 

$

16,670

 

$

18,532

 

 

 

 

 

Outstanding at

 

 

Applicable

Selected Debt Data

 

June 30, 2022

 

 

Interest Rate

Senior Secured Notes due 2028 (1)

$

114,731,000

 

 

7.125

%

Senior Secured Notes due 2024 (2)

$

44,685,000

 

 

6.750

%

(1) $114.7 million notes with semi-annual interest payments at an annual rate of 7.125%.

(2) $44.7 million notes with semi-annual interest payments at an annual rate of 6.750%.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220802006191/en/

Company Contact:
Evan D. Masyr
Executive Vice President and Chief Financial Officer
(805) 384-4512
evan@salemmedia.com

Source: Salem Media Group, Inc.

Released August
4, 2022

 


Release – Cypress Development Announces Drill Results from Clayton Valley Lithium Project, Nevada




Cypress Development Announces Drill Results from Clayton Valley Lithium Project, Nevada

Research, News, and Market Data on Cypress Development

August 4, 2022 – Vancouver, Canada – Cypress
Development Corp. (TSXV: CYP) (OTCQX: CYDVF) (Frankfurt: C1Z1)
 (“Cypress” or “the Company”) is pleased to report results from the recently completed drill program at its 100%-owned Clayton Valley Lithium Project (“Project”), in Nevada, USA. A sonic drill program was conducted in May 2022, to obtain sample material for lithium extraction testing at the Company’s Lithium Extraction Facility (“Pilot Plant”) in Amargosa Valley, Nevada, and to supplement the Project’s resource model for the Feasibility Study that is currently underway.

Highlights:

  • Best intersection of 70.1 meters of 1,336 parts per million (“ppm”) lithium
  • Successful use of sonic drilling to obtain six- and four-inch diameter cores
  • Completed 580 meters in eight drill holes ranging from 61 to 76 meters in depth
  • Acquired 15 tonnes of claystone for testing at the Company’s Pilot Plant
  • Confirmed resource model built by Global Resource Engineering (“GRE”)
  • Confirmed drill data obtained in the acquisition of Enertopia Corporation (“Enertopia”) property

“The drill program was highly successful in generating material for our pilot plant and providing distinct data to strengthen the Project’s resource model” stated Bill Willoughby, Cypress President, and CEO. “These are significant steps as we continue to work to de-risk the project and provide information for the Feasibility Study.”

Drill Program

Cypress has received all assays from its May 2022 drilling program. The program was conducted to collect claystone with large diameter core for use in metallurgical testing at the Company’s Pilot Plant. A total of 580 meters were drilled in eight holes. Hole depths were limited to intersect lithium-bearing claystone to a depth of 61 to 76 meters and to obtain approximately 15 tonnes of material for testing.

Representative core samples ranging from 0.1- to 3-meters in length were collected and delivered to ALS Global in Reno, Nevada for analysis. Lithium values shown in the table are weighted averages over the length of claystone intersected in each hole. All eight holes ended in lithium-bearing claystone. Each sample submittal was accompanied with QA/QC samples of blanks, standards, and duplicates.

DRILL HOLE
NUMBER

UNSAMPLED OVERBURDEN
(METERS)

CLAYSTONE
(METERS)

LITHIUM
(PPM)

CVS1

6.1

70.1

1,336

CVS2

3.0

70.1

805

CVS3

6.1

73.2

1,198

CVS4

3.0

70.1

1,119

CVS5

9.1

73.2

801

CVS6

6.1

51.8

1,264

CVS7

6.1

70.1

1,243

CVS8

6.1

54.9

873

Measurements from surface, samples analysed with four
acid digestion with ICP-MS

Four holes, CSV1 through CVS4, were drilled in the central portion of the Project in the vicinity of the planned starter-pit. CVS2 is located outside of the reserve pit outline from the 2021 Prefeasibility Study, nearest the location of the anticipated plant site for the feasibility study. CVS3 is located adjacent to a reclaimed test pit where 500-tonnes of claystone were collected in April.

Four additional holes, CVS5 through CVS8, were drilled in the northeast portion of the project on and near the parcel of property acquired this year from Enertopia. These holes were arranged southeast to northwest infilling the fence of TOP-01, TOP-02, TOP2M and TOP-04 drilled by Enertopia, and DCH-09 drilled by Cypress.   

Interpretation of Results

The assay results are in line with lithium grades predicted at all eight locations by the resource block model developed by GRE. The overall estimated lithium grade for all eight locations from GRE’s model is 1,060 ppm. This compares to the compiled average lithium grade from all eight holes drilled of 1,080 ppm, for a variance of +2%.

When viewed in cross-section, the assay results are also consistent with those from previous drilling and support the continuation of a higher-grade northeast trend of lithium-bearing claystone on Cypress’s project as interpreted by GRE in developing the resource model. The results are encouraging and have potential to extend the 2021 pit design through Cypress hole DCH-13 (82.3 meters, 1,221 ppm lithium) to CVS6, CVS7 and the northeast corner of the property.

With the drill program completed, GRE will revise and update the resource model with the new data and proceed with work on the mine plan and production schedule for the feasibility study, which is expected to be completed by year end.

Figure 1: Cypress Development
Drill Hole Location Map

Qualified Person

Daniel Kalmbach, CPG, is the qualified person as defined by National Instrument 43-101 and has approved the technical information in this release.

About Cypress Development Corp

Cypress Development Corp. is a Canadian based advanced stage lithium company, focused on developing its 100%-owned Clayton Valley Lithium Project in Nevada, USA. Cypress is in the pilot stage of testing on material from its lithium-bearing claystone deposit and progressing towards completing a feasibility study and permitting, with the goal of becoming a domestic producer of lithium for the growing electric vehicle and battery storage market.

ON BEHALF OF CYPRESS DEVELOPMENT
CORP.

WILLIAM WILLOUGHBY, PhD., PE
President &
Chief Executive Officer

For further information, please
contact:

Spiros Cacos | Vice President, Investor Relations
Direct: +1 604 764 1851 | Toll Free: 1 800 567 8181 | Email scacos@cypressdevelopmentcorp.com
www.cypressdevelopmentcorp.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

Cautionary Note Regarding Forward-Looking Statements
This release
includes certain statements that may be deemed to be “forward-looking
statements”. Forward-looking statements are subject to risks,
uncertainties and assumptions and are identified by words such as “expects,”
“estimates,” “projects,” “anticipates,” “believes,” “could,” “scheduled,” and
other similar words. All statements in this release, other than statements
of historical facts, that address events or developments that management of the
Company expects, are forward-looking statements. Although management believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future
performance, and actual results or developments may differ materially from
those in the forward-looking statements. The Company undertakes no obligation
to update these forward-looking statements if management’s beliefs, estimates
or opinions, or other factors, should change. Factors that could cause actual
results to differ materially from those in forward-looking statements, include
market prices, exploration, and development successes, continued availability
of capital and financing, and general economic, market or business conditions.
Please see the public filings of the Company at www.sedar.com for
further information.